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PREFACE 
Limiting dilution analysis was utilized as a method to estimate the 
frequency of murine tumor associated macrophages (TAM) and normal 
splenic macrophages that secrete tumor necrosis factor (TNF) before and after 
prestimulation with bacterial lipopolysaccharide (LPS). In addition, an MTT 
cytotoxicity assay utilizing anti-TNF polyclonal antibody (a-TNF) to block the 
TNF activity of TAM was used to determine if TNF secretion is solely 
responsible for the tumoricidal activity of TAM. Finally, combinations of 
LPS, macrophage-colony stimulating factor (M-CSF), and gamma- interferon 
(IFN -y) were assessed for their effects on the enhancement of the tumoricidal 
activtity of TNF-secreting tumor associated macrophages (TAM). Analysis of 
the data generated in this study show that only rare subpopulations of TAM 
and normal splenic macrophages can be induced to become cytotoxic. This 
cytotoxic activity is due to the secretion of tumor necrosis factor (1NF) and, in 
both cases, the frequency of these macrophages exhibiting cytotoxic activity is 
strikingly similar. Further analysis of data from MTT cytotoxicity assays 
suggest that the LPS, M-CSF and IFN-y alone or in specific combinations can 
significantly enhance the cytotoxic activity of 1NF-secreting subpopulations 
of tumor associated macrophages. 
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CHAPTER I 
INTRODUCTION 
Macrophages found within solid tumors are usually referred to as tumor 
associated macrophages (TAM). These unique macrophages can comprise as 
few as two or as many as eighty percent of some solid tumors. In addition, 
Mantovani and his coworkers have shown that the relative percentage of 
TAM remains constant throughout most of the tumor life cycle, even during 
rapid growth stages (9). The most reported and perhaps most important 
TAM-mediated activities are enhancement of tumor growth and tumoricidal 
activity (15). However, the precise relationship between TAM and their 
specific tumor hosts remains a matter of conjecture. 
To date, no report can be found in which the frequency of TNF-secreting 
subsets of TAM has been determined. It would therefore be interesting to 
determine the frequency of activated and non-activated TAM that secrete 
TNF and kill tumor cells. Regulation or manipulation of this tumoricidal 
activity, using biologic factors and recombinant cytokines, may eventually 
lead to a new approach to treatment of solid tumors as well as a better 
understanding of the activity and cytotoxic capabilities of normal tissue 
macrophages. 
The statistics-based limiting dilution analysis developed by Leftkovits is 
one experimental approach that can be employed to determine the frequency 
of TNF-secreting subpopulations of tumor associated macrophages (12). 
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Macro phages 
Macrophages are part of the mononuclear phagocytic component of the 
immune system in higher animals. When certain functional genes have 
been activated by receptor-ligand interactions, macrophages are effectors of 
cell-mediated immunity and are capable of many specific functions (29). 
These functions include production of various factors that influence the 
growth of other cell types including macrophages. In addition, other factors, 
shown to be important in the processes of intracellular killing and 
phagocytosis, are also produced by macrophages. These factors are usually 
associated with cytotoxic functions that require activation by cell to cell 
contact (8, 10, 27). In this case, macrophages attach themselves to and destroy 
foreign particles or bacteria through production of toxic oxygen metabolites, 
acid hydrolases and lysosomal degradation of the phagocytized organism or 
particle. At the same time, macrophages are very effective antigen presenting 
cells (APC's) (29). During the phagocytosis process, they can process and 
present foreign antigen to thymus-derived helper T lymphocytes (TH cells). 
This usually results in the induction of a cascade of immune reactions, 
regulatory activities and the activation of a complete immune response (29). 
These and other functions are highly dependent upon effector to target ratios 
and time. Macrophages have a finite state of activation which decays rapidly 
over a period of hours. Cytotoxic activity is therefore a totally reversible and 
highly regulated function (29). 
Some agents, such as growth factors, are constitutively produced and 
secreted by macrophages and represent biologically active factors or cytokines 
that are important in extracellular functions. Other factors in this category are 
secreted only when macrophages have been activated. Macrophage activating 
agents include IFNy, pyrogens, acid hydrolases, prostaglandins and comple-
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ment components (10). In addition, macrophages are capable of repairing 
tissue damage through the production of factors which stimulate growth and 
angiogenesis (29). The production of interleukin-1 (IL-1) and other factors by 
macrophages can lead to induction of fever and inflammatory responses (29). 
Macrophages also have the ability to secrete factors which play important 
regulatory roles. For instance, they can produce factors such as lymphocyte 
activating factor (LAF) which can either suppress or stimulate lymphocyte-
mediated immune responses (10). They can also produce macrophage-colony 
stimulating factor (M-CSF), interleukin-2 (IL-2) and platelet-derived growth 
factor (PDGF). All these factors can stimulate the growth and proliferation of 
a variety of cells such as fibroblasts and other macrophages (10, 25). However, 
some macrophage functions can have negative effects on the host. For 
instance, macrophages can cause tissue damage at the site of a wound or 
bacterial invasion. This is primarily attributable to their production of certain 
enzymes and products of oxidative metabolism (29). Of course, the functional 
activities of macrophages depend upon time, their state of activation, their 
functional roles, effector to target cell ratios and, most importantly, their 
production and release of biologically important factors and cytokines (29). 
Macrophage Morphology and Ontogeny 
Macrophages are ubiquitous throughout the tissues and organs of higher 
organisms (29). Some of the more interesting morphological characteristics 
that are common to most macrophages include their nuclear and cytoplasmic 
characteristics. Macrophages have a kidney-shaped nucleus and a large 
amount of cytoplasm that contains many lysosomes which are primarily 
responsible for their phagocytic activity. In addition, macrophages may 
express a variety of cell surface markers. This marker expression can be 
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constitutive or in response to cellular or microenvironmental factors. Some 
of these markers include adherence (MAC-1), antibody (Fe) and interleukin-2 
(IL-2) receptors, class I and class II major histocompatibility complex 
molecules (MHC), and lymphocyte function associated antigen-3 (LFA-3) (29). 
Two interesting functional characteristics which macrophages share are 
their ability to rapidly adhere to various types of glass or plastic surfaces and 
their ability to form rosettes with opsonized sheep erythrocytes through Fe 
recptor binding (31). These and other functional characteristics (such as 
phagocytosis) are widely used as a means of isolation of macrophages from a 
mixed population and they can also be used as a means of macrophage 
identification (31). 
Normal tissue macrophages are fully differentiated effector cells that are 
derived from short-lived circulating monocyte precursors. The ultimate 
source of macrophages is the bone marrow. Pluripotent stem cells are born in 
the marrow and follow a maturation pathway that leads to the development 
of monoblasts. These, in turn, undergo cell division to produce progeny that 
become promonocytes. Promonocytes quickly produce monocyte progeny 
that enter the blood stream. After circulating in the blood stream for several 
days the undifferentiated monocytes can enter specific tissues and, after 
differentiation and maturation, become resident tissue macrophages that are 
capable of a somewhat longer life span (about five weeks) as well as tissue-
specific biological functions (32). 
It is not clear whether macrophage subpopulations are the product of one 
specific precursor or the product of different precursors. It is clear that, among 
their most important functions, macrophages are capable of promoting the 
growth and proliferation of many cell types through the production of colony 
stimulating factors. Macrophages are also capable of direct bacterial 
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phagocytosis as well as the induction of cytostasis and cytolysis of tumor cells 
through production and secretion of tumor necrosis factor (15). 
Macrophage-Mediated Cytostasis and Cytotoxicity 
Activated macrophages are capable killing highly antigenic tumor cells 
when direct cell to cell contact between effector and the target cell occurs 
(8, 27). This is due to the cytostatic and cytotoxic activities of macrophages. 
Some of the mechanisms involved include the transfer of lysosomes to the 
tumor target, production of neutral proteases which appears to induce 
cytostasis of tumor targets and toxic oxygen metabolites such as superoxide 
anions and hydrogen peroxide which can be directly cytotoxic or mutagenic to 
tumor target cells (27). One of the most important cytokines produced by 
activated macrophages is tumor necrosis factor (TNF) (27). In fact, some 
macrophages, that have been infected with intracellular microorganisms, are 
capable of tumoricidal activity (27). This activity is primarily due to 
activation of the macrophage by lipopolysac-charide (LPS) that may be found 
on the cell surface of the infecting organism or introduced in reagent form 
into experimental systems (27). Macrophage activation seems to induce 
effector to target binding by up-regulating macrophage binding receptor 
synthesis (27). This, in turn, can induce the production and secretion of TNF 
by the macrophage. Consequently, some cytotoxic macrophages can then 
mediate the lysis of sensitive tumor cells by direct cell to cell contact with 
macrophage membrane-associated TNF (16). In contrast, secreted or 
extracellular TNF can also promote lysis of tumor cells within twenty-four 
hours in a manner which is independent of cellular contact (27). 
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Tumor Necrosis Factor 
Lymphocytes, macrophages and other cells of the immune system are 
capable of producing a variety of biologically-active cytokines. Cytokines, of 
course, are cellular messengers that can have a variety of effects including the 
activation or suppression of target cells. These include colony stimulating 
factors, lymphotoxin (LT), gamma interferon (IFN-y), and tumor necrosis 
factor (TNF) (5). The terms cachectin and tumor necrosis factor are often used 
interchangeably to designate a homologous molecule of about seventeen 
kilodaltons (kd). TNF-cx (cachectin) is a polypeptide hormone produced by 
macrophages (5). More recently it has been noted by Aggarwal that TNF-cx 
and TNF-~ (a term often used to denote lymphotoxin) compete for the same 
cellular receptor (3). This shared characteristic suggests that lymphotoxin and 
TNF-cx may share a common heritage within cellular effector pathways (3). 
TNF-~ (LT) and TNF-cx (cachectin) have many closely related biological 
properties in common (5). They can play a substantial role in the induction of 
fever, diarrhea and hypotension which are the same symptoms observed 
during the course of endotoxin-induced shock (5). TNF-cx can alter host 
metabolism by suppressing the lipoprotein lipase activtity of adipocytes. 
TNF-cx is also capable of inducing cachexia which is the general wasting of a 
host that has been afflicted with a chronic disease. The term cachectin is 
perhaps more appropriately applied to the overall activity of these biologically 
important hormones. Finally, cachectin (TNF-cx) can lyse TNF-sensitive 
tumor cells and the term tumor necrosis factor (TNF) is perhaps more 
correctly applied in this case (5). Tumor necrosis factor (TNF) may therefore 
provide the key to understanding the complex nature of solid tumor systems 
and may also provide a powerful weapon in cancer therapy (3, 5). 
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Regulation of TNF Production 
Prostaglandin E2 (PGE2) has been shown to be an important autocrine 
regulator of TNF production. Kristein et al. have shown that activated 
macrophages produced high levels of TNF and low levels of PGE2. However, 
when this activation state declined, so did TNF production and, at the same 
time, the levels of PGE2 correspondingly increased to normal ranges (11). 
Mechanisms of TNF Activity 
Although the exact mechanisms of TNF-induced cytolysis remains a matter 
of conjecture, some interesting theories have recently emerged. The first step 
in killing is most likely the binding of TNF to cell receptors (3). However, it 
should be noted, that many cells within heterogeneous populations express 
TNF receptors but, are not sensitive to the cytolytic effects of TNF (30). One 
major result of TNF-induced cytotoxicity is the indirect degradation of DNA 
that was observed in many types of tumor target cells (2). 
TNF as a Theraputic Agent 
Regardless of the mechanism of TNF-induced cytoxicity the use of tumor 
necrosis factor (TNF) as a chemotheraputic agent in cancer therapy may be 
promising. Balkwill has shown an 85% survival rate of nude (immuno-
compromised) mice that had been given an intraperitoneal tumor injection 
then treated with human recombinant-TNF and gamma interferon (IFNy) 
(4). lFNy has been shown to induce the production of TNF receptors by target 
cells (3). This may explain the synergistic effect of combined IFN-y and TNF 
treatment (3). However, Balkwill also noted that either treatment alone was 
ineffective (4). Besides the most obvious effects of tumor necrosis factor 
(TNF) on tumor growth, TNF may actually select for metastatic behavior by 
depleting only TNF-sensitive tumor cells. Such a selection may result in 
survival of tumor cell subsets that are resistent to destruction by TNF (9). 
Since TNF can be produced by normal tissue and tumor associated 
macrophages much more needs to be learned about this facinating cytokine. 
Tumor Associated Macrophages 
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Unlike normal tissue macrophages, tumor associated macrophages 
(TAM) reside in transformed (tumor) tissue and can represent a substantial 
portion (up to 80%) of a tumor mass. The ratio of TAM to tumor cells remain 
constant during tumor growth and, like their normal macrophage counter-
parts, appear to share many of the same biological functions (15). Some of the 
functions they share include the production of biologically important factors, 
expression of cell surface molecules (such as MHC II and Fe receptors), antigen 
presenting capabilities, secretion of TNF and cytotoxic activity (9, 14, 15). 
TAM Heterogeneity 
Tumor associated macrophages (TAM) are characteristically quite hetero-
genous within their tumor environment. However, two phenotypically 
distinct subpopulations have been described (16). These TAM differ in size 
and are separated on the basis of velocity sedimentation. One subpopulation, 
consists of relatively large, peroxidase-negative TAM that express high levels 
of MHC II molecules and high avidity Fe receptors (FeR). The other 
subpopulation consists of smaller TAM that are peroxidase-positive, have 
lower avidity FeR and may represent less mature TAM (15). In fact, Moore 
and McBride have suggested that the smaller TAM may mature into the 
larger ones and, in the process, lose their peroxidase activity (16). 
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Proliferation of TAM 
Even during rapid tumor growth, TAM can constitute a substantial portion 
of the tumor mass (9). It is unclear whether TAM are the progeny of 
circulating monocytes (which may have entered the tumor environment 
from the bloodstream) or a product of intratumoral proliferation or both (14). 
However, TAM have recently been shown to express receptors for M-CSF (19). 
More recently, TAM, from solid murine tumors, demonstrated an increased 
capacity to proliferate in vitro when treated with recombinant M-CSF (20). It 
is interesting to note several investigators have demonstrated the induction 
of various differentiation activities of mature macrophages after activation 
with M-CSF (19, 22). 
TAM Functional Activities 
TAM have many interesting functional characteristics that may help 
provide insight into the functions and activities of all macrophages. TAM 
have been shown to be capable of secreting cellular growth enhancement 
molecules and cytokines (14, 15). These may include procoagulants (PCA's) 
which can lead to the increased formation of fibrin and may subsequently aid 
tumor cell motility, the formation of intratumoral vascular networks 
(angiogenesis) and the inducement or suppression of effector cell entry into 
the tumor mass (14). These and other TAM functions such as production of 
platelet-derived growth factor (PDGF) and interleukin-1 (IL-1) parallel the 
growth enhancement activities of normal tissue macrophages (7, 14). 
However, TAM reside in tumor tissue and, in some cases, may therefore help 
promote the growth and proliferation of potentially lethal tumor masses (14). 
Much like their normal tissue counterparts, TAM can produce agents 
which may aid in tumor invasion and metastasis. These include protease 
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enzymes like elastase and collagenase as well as toxic oxygen metabolites (14). 
Some of these metabolites like superoxide and hydrogen peroxide (H202) can 
be mutagenic (1). These metabolites can aid in the tumoricidal effects of TAM 
in vivo and, at the same time, they can have the effect of minimizing host 
defenses by increasing tumor heterogeneity through mutagenesis (14). 
Perhaps the most interesting, yet intriguing, function of some tumor 
associated macrophage subsets is their ability to become tumoricidal when 
activated (15). TAM, found at secondary sites of tumor invasion, can produce 
and secrete TNF and are thus quite often tumoricidal. In addition, they are 
usually present in higher ratios at these sites and seem to have the ability to 
partially block tumor metastasis (14). 
Limiting Dilution Analysis 
Until recently, the elucidation of cellular activity was limited in its scope by 
the need for an assay with the sensitivity to accurately detect very small 
amounts of activity and, at the same time, distinguish between functionally 
distinct subpopulations. Limiting dilution analysis (LDA) can be employed to 
elucidate kinetic events. Consequently, when single-hit kinetics are observed, 
LDA can be used to determine the frequency of TNF-secreting TAM, within a 
heterogeneous TAM population, which exhibit cytotoxic or tumoricidal 
activity (12). Limiting dilution analysis (LDA) can also be used to determine 
whether tumoricidal TAM require cell to cell interactions with other 
phenotypes before expressing their activity. This requirement would indicate 
multi-hit relationship and would be reflected, in the LDA, as a non-linear 
event (13). The LDA is a statistical analysis based on binomial (dependent) 
and Poisson (discrete) distributions. This unique analysis permits the 
investigator to extrapolate the specific activity of a small experimental 
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population of tumor associated macrophages to an entire population of 
tumor associated macrophages when there is a linear or single-hit 
relationship (13). Because sufficient data, concerning the frequency of TAM 
that secrete TNF is currently unavailable, a limiting dilution analysis (LOA) 
was employed in this study because it allows for the estimation of the 
frequency of TNF-secreting TAM within an experimental population (12). 
The major goal of this study is to use a limiting dilution analysis to 
determine the frequency of experimental murine splenic macrophages and 
MC-4 and lX-11-6 TAM that secrete TNF in response to LPS. In addition, anti-
TNF antisera (anti-TNF-a) will be used to block the cytotoxic activity of these 
TAM in an effort to show direct evidence that TNF is secreted by TAM and is 
responsible for their cytotoxic activity. Finally, LPS, M-CSF and IFN-y will be 
assessed by an MIT assay as well as dot plot and mean absorbance comparison 
analysis for their effects on the cytotoxic activity of lX-11-6 TAM. The results 
of this study should provide additional data concerning the cytotoxic activity 
of TAM and further insight into the functions of normal tissue macrophages. 
CHAPTER IT 
METHODS AND MATERIALS 
Experimental Animals 
Female, C3H/HeN mice were obtained from Charles River (Wilmington, 
Massachusettes) and used as experimental animals throughout this study. 
All mice were about seven weeks old and kept at an animal care facility at 
Oklahoma State University. Prior to organ and tumor removal, etherization 
(as opposed to other methods which would allow blood to enter the 
peritoneal cavity) was used in all experiments as a humane method of 
euthanasia . 
Media, Buffers and Reagents 
All cells, used in experiments and in the generation of cytokines, were 
diluted and cultured in complete RPMI (cRPMI) medium. Powdered RPMI as 
well as the components to complete the medium and insure its microbial 
quality were obtained from Sigma Chemical Corporation (St.Louis, MO). 
Complete RPMI was prepared in the following manner. Powdered RPMI was 
reconstituted in reverse osmosis/ double distilled water with 2 grams of 
sodium bicarbonate per liter of prepared medium. Sodium pyruvate (1.0 
mM), L-glutamine (2 mM), 5% (v /v) fetal bovine serum (heat inactivated for 
30 minutes in a water bath at 56° C), nonessential amino acids (those that 
were not used to supply nitrogen) (1.0 mM) were used to complete the RPMI. 
12 
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In addition, amphotericin B (2.5 mg/ml), penicillin (100 mg/ml), strepto-
mycin (0.1 mg/ml) and gentamycin sulfate (50 mg/ml) were added to inhibit 
microbial contamination during incubation and storage. After the pH of the 
cRPMI was adjusted to 7.2, the completed medium was then filter sterilized 
through 0.45 J.lffi sterile disposable filters (Fisher, Sci. Co., Norcross, Ga) into 
sterile (autoclaved, 15 psi/15 min) 500 ml glass bottles and stored at 40 C prior 
to use. 
Freezing medium was used throughout this study to preserve cell lines. 
Concentrated cells were aseptically dispensed into 1 ml aliquots of freezing 
medium and stored in a liquid nitrogen-cooled chamber at -273° C. Freezing 
medium was prepared by adding 9.5 milliliters of calf serum (Sigma, 95%) to 
0.5 milliliters of anhydrous dimethyl sulfoxide (DMSO) (Sigma, 5%), filter 
sterilizing the mixture through 0.22 Jlm sterile disposable filters (Fisher, Inc.) 
into sterile (autoclaved) screw-capped test tubes and storing the medium at 
4° C until needed. 
Buffers were primarily used in this study to prepare reagents and wash, 
dilute or lyse cells. Phosphate buffered saline (PBS, 0.05 M P04) was used as a 
diluting and washing buffer and to prepare reagents. PBS was prepared in 
one liter quantities by adding monobasic potassium phosphate (Fisher, 
KH2P04 · H20, 2.7 g/L), sodium chloride (Baker Chern. Co., Phillipsburg, NJ., 
NaCL, 4.1 g/L) and anhydrous sodium phosphate (Sigma, Inc. Na2HP04 
10.57 g/L) to one liter of double distilled water, adjusting the pH to 7.4 and 
sterilizing the PBS by autoclaving at 15 psi for 15 minutes. 
Lysing buffer (Tris-buffered ammonium chloride) was used to lyse sheep 
red blood cells (SRBCs) during the process of isolating macrophages (see 
isolation of tumor associated macrophages, page 19). Lysing buffer was 
prepared by adding 50 ml of a 2.06% (w /v) sterile H20 solution of tris base 
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(Sigma, 20.6 g/L), that had been adjusted to a pH of 7.6, to 450 ml of an 0.83% 
(w /v) solution of ammonium chloride (Sigma. 8.3 g NH4 CL/L). Following 
thorough mixing, the pH of the lysing buffer was adjusted to 7.2 with HCL 
and, after adjustment of the pH, the lysing buffer was filter sterilized through 
0.45 Jlm sterile disposable filters (Fisher) into sterile (autoclaved, 15 
psi./15min) 500 ml bottles. 
The enzyme reagents used in this study were used and prepared in the 
following manner. Collagenase-dispase is a mixture of enzymes and was 
used as an agent to enzymatically dissolve the connective tissue of tumor 
fragments and produce single tumor cell suspensions. Collagenase-dispase 
(0.10% w/v) was prepared by adding 0.10 grams of collagenase (Sigma, St. 
Louis MO, 0.001 g/ml) and 0.10 ml of dispase (Boehringer Mannheim, GmbH, 
W. Germany, 0.001 g/ml) to 100 ml of sterile PBS, adjusting the pH to 7.4 and 
immediately filter sterilizing the resulting mixture through 0.22 IJ.m sterile 
disposable filters into sterile (autoclaved) 150 ml bottles. The collagenase-
dispase was then aseptically aliquoted, in 25 ml quantities, into sterile screw-
capped test tubes and preserved, at -20° C, prior to use. 
Trypsin-EDTA was used in this study to enzymatically remove confluent 
cell layers during cell culture maintenance. Trypsin-EDTA was prepared by 
adding 0.25 grams of trypsin (Sigma, 0.25% w/v) and 0.0292 grams of 
anhydrous ethylene diamino tetraacetic acid (EDTA) (Sigma, 1 mM) to 100 ml 
of sterile PBS, adjusting the pH to 7.4 and filter sterilizing through sterile 0.22 
IJ.m filters into sterile 150 ml reagent bottles and stored at 4° C prior to use. 
MIT was used as a colorimetric reagent in dose response and cytotoxicity 
assays in this study. MTT [ Sigma, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide) ] is a disubstituted tetrazolium salt that can be biochem-
ically converted to formazan crystals by viable (living) cells. Following 
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formation, the crystals can be solubilized with isopropanol-HCL (0.04 N). The 
product (solubilized formazan) can then be quantitatively detected with the 
aid of an ELISA plate reader at a wavelength of 570 nanometers. MTT was 
prepared in the following manner. Fifty milligrams of MTT (Sigma, 
5 mg/ml) was added to 10 ml of sterile PBS, the mixture filter sterilized 
through 0.22 Jlm sterile disposable filters into sterile 20 ml screw-capped test 
tubes and stored at 4° C until needed. 
Isopropanol-HCL (0.04 N) was used, as previously discussed, to solubilize 
formazan crystals and was prepared by aseptically mixing 100 ml of anhydrous 
isopropanol (2-propanol) (EM Sci., Inc., Cherry Hill, NJ., 100%) with 0.333 ml 
of concentrated, aquaeous hydrochloric acid (MCB, Cincinnati, OH., 12 N). 
Following preparation, isopropanol-HCL was stored in a flameproof cabinet 
until needed. 
To determine the frequency of activated macrophages that secrete tumor 
necrosis factor (TNF) and to evaluate the cytotoxic activity of TAM, several 
agents were used to stimulate TAM, and other effector cells, to secrete TNF. 
These agents were prepared in the following manner. Bacterial lipo-
polysaccharide (LPS) (Sigma, St. Louis, MO) was aseptically diluted in sterile 
PBS. LPS was then added to TAM cells at a concentration of 5Jlg LPS/ml to 
stimulate TNF secretion. Recombinant mouse gamma-interferon (IFN-y) 
(kindly provided by Genentech, Inc., San Francisco, CA., 200,000 units/ml) 
and recombinant Macrophage-colony stimulating factor (rM-CSF) (kindly 
provided by Cetus, Emeryville, CA., 5 x 105 units/ml) were also used to 
stimulate TNF secretion. Both were prepared by diluting a portion of the 
stock solutions of IFN-y and M-CSF to appropriate concentrations in sterile 
PBS substituted with 1% fetal bovine serum. Stock solutions were preserved 
by freezer storage at -70° C and aliquotes of diluted IFN-y and M-CSF were 
immediately used in LDA and other assays. 
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Whole rabbit anti-mouse TNF-a antisera (anti-TNF-a) (Genzyme, Boston 
MA., 1 x 106 neutralizing units/ml) was used to show that TNF secretion is 
responsible for the the cytotoxicity activity of TAM. This was accomplished by 
using anti-TNF-a antisera to neutralize the TNF activity of TAM. Anti-
TNF-a antisera was prepared by aseptically diluting a portion of stock solution 
to the appropriate concentration in sterile RPMI medium and used 
immediately. Again, the stock solution of anti-TNF-a was preserved by 
freezer storage. 
Cell Culture Maintenance 
WEHI-164 tumor cells (American Type Culture Collection, Rockville, MD) 
are methylcholanthrene-induced mouse fibrosarcomas. WEHI-164 cells were 
originally established, after subcutaneous injection of BALB/C mice with 
3-methylcholanthrene, by M. Rollinghoff and N.L. Warner. WEHI-164 tumor 
cells and cells from a very TNF-sensitive WEHI-164 tumor cell clone (2/F2 ), 
generated in Dr. Kim Burnham's lab by limiting dilution cloning, were used 
in this study as target cells. During periods of use, cultures of target cells were 
maintained in 50 ml tissue culture-treated cell culture flasks (Fisher), 
periodically replenished with cRPMI and incubated at 371 C in an atmosphere 
of 95% air and 5% C02. When culture growth approached monolayer 
confluency (as determined through phase contrast microscopy), the cells were 
subsequently subcultured within 24 hours in the following manner. The 
depleted medium was discarded and the culture gently rinsed with 5-10 ml of 
phosphate buffered saline (PBS) (0.05 M P04, pH 7.4). To remove the 
confluent cell layer, 1 ml of trypsin-EDTA (0.25% w/v trypsin and 1 mM 
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EDTA in PBS) was pipetted into the flask then the flask was incubated at 3i' C 
for 10 minutes. After incubation, 5 ml of cRPMI was added to the flask to stop 
the enzyme reaction, the flaskwas subsequently tapped to remove additional 
cell masses and rinsed with 5-10 ml of PBS. Prior to incubation, 30 ml of 
cRPMI was added to allow new culture growth. 
Isolation of Splenic Macrophages 
Splenic macrophages were obtained sugically from Normal C3H/HeN 
mice. Mice were euthanized in an ether jar prior to removing the peritoneal 
cavity skin. The peritoneal cavity was then opened and the spleens surgically 
removed. The spleens were transferred to a small (60 x 15 mm) sterile culture 
dish (Baxter, Inc., Grand Prarie TX.) containing cold (4° C) PBS and kept on ice 
prior to removing splenic macrophages. In the hood, splenic macrophages 
were squeezed out of the spleen sac with gentle pressure using a sterile scalpel 
and forceps. Once the cells were obtained the depleted spleen sac and large 
tissue fragments were discarded. The crude macrophage suspensions were 
then transferred to a large (10 ml) sterile screw-capped test tube and washed by 
centrifugation at 650 g for 10 minutes. After centrifugation, the supernatants 
were discarded and, depending on the experiment, the concentrated splenic 
macrophages were diluted to the appropriate concentration in cRPMI. 
Generation of Crude Tumor Necrosis Factor 
Crude natural tumor necrosis factor (TNF) preparations were generated 
in 20 ml of cRPMI by culturing LP5-treated spleen cells from normal mice in 
the following manner. To induce the production of TNF by normal splenic 
macrophages, LPS (5Jlg/ml) was added to the diluted macrophages. The LPS-
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treated suspensions were then dispensed, in 20 ml aliquots, into sterile 15 
mm culture plates and incubated 24 hours at 37'l C. After incubation, the 
supernatants were harvested and centrifuged at 650 g for 10 minutes to pellet 
residual cells. The crude TNF suspensions were then dispensed, in 20 ml 
aliquots, into sterile test tubes and stored at -20° C until needed. 
Sheep Erythrocytes 
Sheep erythrocytes (SRBCs) were obtained from Organon Teknika 
(Durham, North Carolina) and from the college of Veterinary Medicine at 
Oklahoma State University. SRBCs were stored at 4° C prior to use in 
experiments. Ten percent solutions of SRBCs were prepared for use in 
experiments by first washing the SRBCs in the following manner. PBS was 
added to the SRBCs with gentle mixing. To concentrate the SRBCs, the 
mixture was centrifuged for 10 minutes at 650 g (1500 RPM). Following 
centrifugation, the cloudy supernatant was gently removed with a 5 ml 
pipette and replaced with an equal volume of PBS. The procedure was then 
repeated three or more times until the supernatant became clear. After 
washing, the concentrated SRBCs were then diluted to 10% v /v in PBS and 
used in appropriate experiments. 
Generation of Tumor Associated Macrophages 
The tumor associated macrophages (TAM) used in this study were derived 
from two different sources. The first source for TAM was a tumor line 
designated as MC-4. MC-4 tumors were generated by injecting normal 
C3H/HeN female mice with methylcholanthrene (MCA) (Sigma). Briefly, 
1 mg of MCA was dissolved in 50 Jll of olive oil and subcutaneously injected 
at the ventral surface of each mouse. Subsequent passage of the MC-4 tumor 
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line into secondary hosts was accomplished by subcutaneous injection of 2-3 
small MC-4 fragments into normal C3H/HeN mice. The second source for 
TAM was a tumor designated as 1X-11-6 and was obtained from Dr. James 
Beeson at the University of Oklahoma at Tulsa Medical College. Tumor line 
1X-11-6 arose spontaneously from an in vitro culture of C3H/HeN placental 
tissue. Subsequent passage of the 1X-11-6 tumor line was accomplished in the 
same manner as the the MC-4line. Tumors were excised from euthanized 
mice two to four weeks after the tumors were implanted into secondary hosts. 
Following excision, the tumors were enzymatically dissociated into single cell 
suspensions. This was accomplished by cutting the tumors into fragments 
and incubating them in a mechanically stirred mixture of 0.1% w /v 
collagenase plus 0.1% w /v dispase at 3i> C for approximately one hour. The 
dissociated tumor cell suspension was then centrifuged at 650 g for 10 
minutes and, following centrifugation, the pellet was then resuspended in 
2 mls of cRPMI. The cell concentration was then determined with a 
hemacytometer and diluted (depending on the method of isolation and 
experiment) to the appropriate concentration. 
Isolation of Tumor Associated Macrophages 
To determine the most efficient and practical method for isolating TAM, 
three methods were used. At first, TAM were isolated by density gradient 
exclusion over ficoll hypaque gradient reagent. Single cell suspensions from 
dissociated tumor fragments were diluted to 2 x107 cells/ml then mixed with 
an equal volume of 5% Rabbit anti-SRBC-Ig (Sigma) coated SRBCs (opsonized 
SRBCs) and incubated on a vertical rotator at 3il C for 30 minutes. The 
percentage of rosetted cells (TAM) was then determined with a hemacyto-
meter. Rosetted cells were separated by gently layering the rosetted cell 
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suspension over 3 mls of ficoll hypaque (Sigma Inc., specific gravity 1.119) and 
centrifuging for 20 minutes at 1100 g. Following centrifugation, the 
supernatant was discarded, the harvested pellet resuspended in 2 mls of 
cRPMI medium and the ficoll hypaque separation, centrifugation and 
harvesting process was repeated. Once again the percent of rosettes were 
determined with the aid of a hemacytometer. The suspension was then 
centrifuged at 650 g for 10 minutes to concentrate the rosetted cells. To release 
TAM, SRBCs were lysed by adding one milliliter of sterile double distilled 
water followed immediately by the addition of 5 mls of cRPMI to prevent the 
lysis of TAM. The TAM were pelleted by centrifuging the cell suspension at 
650 g for 10 minutes. After centrifugation TAM pellets were resuspended in 2 
mls of cRPMI and counted with the aid of a hemacytometer. After counting, 
TAM were diluted to appropriate concentrations and used as effector cells in 
limiting dilution analysis or other assays. 
The second method used to isolate TAM was Magnetic bead hybrid 
rosetting (MBHR). In this procedure, sheep anti-rat IgG coated M-450 
magnetic beads (dynabeads) (DYNAL A.S. Corp., Oslo, Norway) were allowed 
to bind specifcially to opsonized SRBCs to produce dynabead rosettes (DBRs). 
Dynabead rosettes were immediately added to a TAM containing tumor cell 
suspension and allowed to bind to Fe receptor positive (FeR+) TAM. This 
process which subsequently produced magnetic bead hybrid rosettes (MBHR). 
MBHR were immunomagnetically isolated from tumor cells suspensions in 
the strong magnetic field of a DYNAL MPC-1 magnetic partical concentrator 
(DYNAL, coehesive force: 8250-8750 oersted). After washing the MBHR five 
times in the magnetic field with cold (4° C) PBS, the SRBCs were lysed with 
lysing buffer. Used Dynabeads were recovered in the magnetic field and the 
isolated TAM recovered in the MBHR effluent. After recovery, TAM were 
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washed in PBS, concentrated by centrifugation at 650 g for 10 minutes and 
resuspended in 5 ml of cRPMI. Following resuspension, the freshly isolated 
TAM were counted with the aid of a hemacytometer, diluted to appropriate 
concentrations in cRPMI and used as effector cells in limiting dilution 
analysis. 
The third and final method used to isolate TAM was adherence (6). The 
adherence method was used to positively select for (desirable) cells such as 
splenic and tumor associated macrophages and to simultaneously exclude 
(undesirable) tumor cells or non-adherent cells . Briefly, heterogeneous 
tumor cell suspensions were aseptically added to 60 x 15 mm tissue culture-
treated culture dishes (Baxter) at a concentration of 3 x 106 cells per milliliter 
of cRPMI medium then incubated for 30 minutes at 37> C in an atmosphere of 
95% air and 5% C02. Incubation for 30 minutes allowed time for macro-
phages to adhere to the bottom of the culture dish. However, the incubation 
period was not long enough for most tumor and other undesirable cells to 
adhere. Consequently, undesirable cells were removed after incubation by 
gently rinsing the culture dishes 5-6 times with sterile PBS. After washing, 
adherent cells were recovered by adding 2 ml of fresh, sterile PBS to the 
washed plates and gently removing the adherent layer with a cell scraper 
(Baxter). Adherent cell suspensions were then added to sterile 10 ml test 
tubes and concentrated by centrifugation at 650 g for 15 minutes. Following 
concentration, adherent cells were resuspended in 1-2 ml of sterile cRPMI and 
counted on a hemacytometer. Portions of the adherent cells were then tested 
for purity by methods which included microscopic morphological analysis 
and rosetting a portion of the adherent cells with opsonized SRBCs to 
determine the percent rosettes. Adherent cells were then diluted to 
appropriate concentrations in cRPMI and used immediately in limiting 
dilution analysis, dose response and MTI cytotoxicity assays. Adherence 
proved to be the most practical method of isolating TAM in terms of speed, 
convenience, costs and accuracy and was therefore used exclusively as a 
method of choice, for isolating TAM and other effector cells, in the latter 
stages of this study. 
Generation of Highly TNF-Sensitive 
WEHI-164 Tumor Cell Clones 
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To determine the frequency of TAM that secrete TNF as well as the 
cytotoxic activity of TAM, it was necessary to generate extremely TNF-
sensitive target clones. Cloning was accomplished by diluting TNF-sensitive 
WEHI-164 tumor cells to a concentration of 3 cells/ml in cRPMI, distributing 
the cells at a frequency of one cell for every two wells by aliquoting 100 JJ.l of 
cell suspension into each well of a sterile 96 well microtiter plate. Following 
distribution, the plates were incubated at 3i> C and monitored daily for the 
appearance of single cell distributions, then allowed to grow to confluency. 
Confluent cell layers that were derived from single cells were subsequently 
removed by trypsinization. The resulting clone suspensions were then 
washed in sterile PBS, resuspended in 2 ml of cRPMI and replated into sterile 
24 well microculture plates. The clones were then incubated at 3i> C and 
allowed to grow to confluency. Following four to seven days of incubation, 
the confluent clones were once again removed by trypsinization, washed in 
PBS, resuspended in cRPMI and reincubated in 30 ml of cRPMI in 50 ml tissue 
culture flasks. The clones were subsequently incubated at 3i> C and 
monitored daily prior to testing for their sensitivity to TNF. Following 
testing, clones were concentrated, resuspended in 1 ml of freezing medium 
and cryogenically preserved in a liquid nitrogen chamber. 
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MIT Assays 
In this study, colorimetric (MIT) assays were used as a basis for cytotoxicity 
and dose response assays as well as limiting dilution analysis. More specific-
ally, MIT assays were used throughout this study to photometrically 
quantitate absorbance values generated by viable target cells. This data was 
used to determine the cytotoxic activity of TAM and to measure the extent of 
killing of 2/F2 target cells (TNF-sensitive WEHI-164 clone) by TAM and other 
macrophage supernatants. After target cells had been incubated with super-
natants, MIT (Sigma, 5 mg/ml) was added to target wells and the target plates 
reincubated for 6 hours at 37> C. Incubation allows time for conversion of the 
MIT reagent to formazan crystals by viable cells. Following incubation, the 
formazan product was then solubilized with isopropanol-HCL (0.04 N). 
Solubilization produces a colored product that can be quantitated, at a 
wavelength of 570 nm, on an ELISA plate reader. The intensity of the color 
(absorbance or optical density) of each well is directly proportional to the 
amount of formazan produced by viable target cells and is therefore inversely 
proportional to the number of sensitve target cells that had been killed by 
macrophage super-natants (17). Once the absorbance data, generated in MIT 
assays, was collected it was collated and analyzed on a dot plot graph to 
distinguish responding wells from nonresponding wells. The data from dot 
plot analysis was then used as a basis for limiting dilution analysis as well as 
cytotoxicity and dose response assays. 
Limiting Dilution Analysis 
Limiting Dilution Analysis (LDA) is a statistical analysis developed by Ivan 
Leftkovits (13). Using the data generated from an experimental population, 
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LDA is often used to make accurate assessments of the cellular functions and 
activities of an entire population. In this study, LDA was used to estimate the 
frequency of macrophages that secrete tumor necrosis factor. LDA is based on 
a formula derived from Binomial and Poisson distributions. Briefly, the 
formula for the zero term of this distribution is defined by the equation 
F0 = e-J.l where; F0 is the fraction of nonresponding wells and J.1 is the mean 
number of responding cells per well (13). However, it is only possible to apply 
Poisson distributions if responding cells are truly limiting. If they are not 
truly limiting, a straight line is not observed and multi-hit kinetics are 
implied. This type of cooperativity violates the assumptions which govern 
Poisson distributions. A multi-hit event indicates that the response to be 
measured is modulated by other factors or other cell types. This is because the 
probability that two or more rare cell types will be placed in the same well 
increases exponentially with the cell density (13). 
Linearity or single-hit kinetics is attained when the mean number of 
responding cells is directly proportional to the negative logarithm of the 
fraction of nonresponding wells. Single-hit events are therefore expressed 
mathematically as J.1 = -lnF0 and, in this case, a straight line that dissects the 
origin is observed when cell concentrations are plotted against the log of F0 . 
It is important to note that if single-hit kinetics (linearity) are observed, J.1 is 
equal to 1 when F0 is equal to 0.37. This means that there is an average of one 
responding cell per well when 37% of the wells are non-responding (13). 
Consequently, when linearity is observed, the inverse of the cell concentra-
tion where 37% of the wells do not respond can be used as an accurate 
estimation of the frequency of responding cells (13). In this study, responding 
cells secrete TNF. LDA was used to measure the frequency of effector cells 
(untreated or LP5-prestimulated TAM or splenic macrophages) that are 
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capable of secreting TNF. Briefly, wells that had been diluted in cRPMI, were 
set up in 96 well tissue culture-treated microtiter plates ( Fisher ). To insure 
that the data would be statistically significant, sixty wells of both effector and 
corresponding target plates were used at each effector cell concentration. In 
every experiment wells containing treated or untreated cells were used as 
comparison controls. In addition, twelve wells, containing no cells, were 
used to establish absorbance baselines. In this case, the supernatants from the 
effector plates were transferred to corresponding cell-free target control wells. 
Effector plates were subsequently incubated. After incubation, supernatants 
were transferred from the effector wells to corresponding target wells. After 
48 hours of incubation an MTT assay was performed on each target plate. The 
absorbance data was collected from these assays and plotted on a dot plot as 
the concentration of effector cells versus target well absorbance values. An 
absorbance response line was then established on the dot plot by determining 
the mean absorbance of the controls (C) and subtracting one standard 
deviation (S.D.). This line has no statistical significance and is used to simply 
delineate responding wells (those having at least one + cell) from non-
responding wells. Dot plot data were subsequently plotted as the macrophage 
concentration versus F0 on an LDA graph. The resulting line that is 
generated on the LDA was then examined for statistical significance by 
Pearson's method of linear regression analysis (26). Following this analysis, 
the coefficient of linearity (at the 95% level of confidence) was determined by 
the least squares method (see Table I.). Experimental results were, depending 
on the degrees of freedom, accepted or rejected on the basis of linearity and 
statistical significance. 
TABLE I 
VALUES FOR PEARSON'S COEFFICIENTS DETERMINED 
BY LINEAR REGRESSION ANALYSIS OF THE DATA 
AT THE 5% LEVEL OF SIGNIFICANCE 
1 Degrees of Freedom 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
2Value of Rl\2 
0.997 
0.950 
0.878 
0.811 
0.754 
0.707 
0.666 
0.632 
0.602 
0.576 
1Degrees of freedom are equal to the number of data points 
in the line (excluding the origin) minus 1. 
2Value of RA2 represents the Pearson's coefficient (26) deter-
mined by linear regression analysis of the data. 
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CHAPTER III 
RESULTS 
Determining the frequency of TAM that secrete TNF was the primary goal 
of this study. Limiting dilution analysis was exclusively utilized to 
accomplish this goal because it allows for the detection of both common and 
rare cell types with specific activities. In this case, limiting dilution analysis 
was used to estimate the frequency of TAM with TNF-secreting activity. In 
addition, limiting dilution analysis can also be used to determine whether 
other cell types are positively or negatively influencing this activity. The 
second major goal of this study was to measure the cytotoxic activity of TAM 
in response to the biological agent LPS as well as M-CSF and IFN-y cytokines. 
To accomplish this goat it was necessary to determine the amount of killing 
of sensitive 2/F2 target cells by supernatants from TAM that were 
prestimulated with LPS, M-CSF and IFN-y. Here, an MIT cytotoxicity assay 
was used to determine the mean absorbances of treated and untreated target 
wells. Comparison of mean absorbances were then used to determine the 
percent killing of target cells and thus estimate the change in the cytotoxic 
activity of TAM. 
Response of WEHI-164 Tumor Targets to Supernatants 
from C3H/HeN Murine Splenic Macrophages 
It was assumed that tumor target cells had to be very sensitive in order to 
use a limiting dilution analysis to detect a single TAM, within an 
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experimental population, with TNF secreting capabilities. Consequently, it 
was first necessary to determine the sensitivity of heterogenous WEHI-164 
tumor cells to TNF. Sensitivity testing was accomplished by limiting dilution 
analysis (LDA). Briefly, 50 JJ.l of supernatants from 24 hour bulk splenic 
macrophage cultures were added to corresponding wells containing 
WEHI-164 target cells. Spleen cell suspensions that contained splenic macro-
phages (effector cells) were prestimulated with LPS (5 JJ.g/ml) and, prior to 
incubation at 3il C in a 5 % C02 incubator, aliqouted into effector plates at 
concentrations of 100,300 and 500 cells per well. Target cells were added to 60 
test wells of each corresponding target plate and used at a single concentration 
of 2.5 x 103 cells/well. Twelve control wells (C) were also added to target 
plates to establish a mean absorbance response line. Also, twelve additional 
control wells of this type were added to the 300 cell/well target plate and used 
to determine whether target cells interfere with test absorbance readings. In 
addition 12 control wells were added to target plates to establish absorbance 
baselines. In this case, controls contained target cells that were not pulsed 
with macrophage (effector) supernatants. Effector cell supernatants were 
added to the target test wells and all target plates were then incubated for 48 
hours at 3il C. After incubation, an MTT cytotoxicity assay was performed. 
on the target plates a.s described in Chapter II, Methods and Materials. 
Following the collection of the absorbance data dot plot analysis showed 
that the mean absorbance of the 12 control wells minus one standard 
deviation (C- S.D.) provided an absorbance response line of 0.087 and was 
used to distinguish responding from non-responding wells (figure 1.). The 
mean absorbance value of the additional controls was 0.007. This value 
indicated that tumor target cells were significantly lysed during solubilization 
and do not alter the absorbance values generated in the MTT assay. 
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Figure 1. Dot Plot Analysis of the Effects of Supernatants 
from LPS-Prestimulated Splenic Macrophages on 
WEHI-164 Tumor Targets. 
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C -S.D. 
Absorbance values of the test wells decreased as effector cell concentration 
increased. This decrease indicated that WEHI-164 tumor target cells are 
increasingly killed at higher concentrations of effector cells. 
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Limiting dilution analysis of the dot plot data, generated by spleen cell 
(macrophage) supernatants, showed that the LDA plot did not yield a straight 
line, single-hit kinetics were not observed and the frequency of TNF-secreting 
splenic macrophages could not be determined (figure 2.). The results, plotted 
on the LDA graph, also included 95% confidence intervals and, in this case, 
the results indicated that heterogenous WEHI-164 tumor targets lacked the 
necessary TNF sensitivity to be used in this study. 
Response of TNF-Sensitive WEHI-164 
Clones to Crude Natural TNF 
The results of the previous experiment indicated that our assay lacked 
sensitivity and therefore indicated the need to generate a highly TNF-
sensitive tumor cell clone. This clone would be used as a target throughout 
this study to estimate the frequency and cytotoxic activity of TNF-secreting 
TAM. Generation of sensitive clones was accomplished by testing WEHI-164 
tumor cell clones for their sensitivity to killing by crude natural TNF 
supernatants. Briefly, 50 J,J.l of 1.25 x 104 cell/ml cRPMI suspension of each 
clone, generated in the protocol described in chapter II, Methods and 
Materials, were added to 12 wells of a sterile 96 well microtiter plate. 
Subsequently, 50 J.ll of a 1:20 solution of crude TNF was added to 6 wells of 
each 12 well test series. In contrast, 50 J.ll of cRPMI was added to the 
remaining 6 wells as comparison controls. Also, 50 J.ll each of cRPMI and 
crude 1:20 TNF supernatant was added to 12 additional, cell-free wells of each 
test plate and used to establish absorbance baselines. Target plates were 
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Figure 2. Limiting Dilution Analysis of the Effects 
of Supernatants From LPS-Prestimulated Splenic 
Macrophages on WEHI-164 Tumor Targets. 
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then incubated for 48 hours at 37° C. After incubation, an MTT cytotoxicity 
assay was performed (as previously described) on each target plate. The 
absorbance data were then analyzed to determine the sensitivity of each test 
clone to TNF. Sensitivity, in this case, was measured as the percent killed 
(%killed). The results showed that the most sensitive clone was those 
designated as 2/F2 (see Table IT). Here, 92% of the 2/F2 cells were killed in the 
presence of macrophage supernatants. Highly sensitive 2/F2 clone cells were 
subsequently used as tumor targets in this study because they seemed to be 
sensitive enough to detect one effector cell, within a heterogeneous experi-
mental population, with TNF secreting capabilities, 
Response of Sensitive 2/F2 Tumor Targets to Supernatants 
from C3H/HeN Murine Splenic Macrophages 
Because they were most sensitive to macrophage supernatants, cells of 
WEHI-164 clone 2/F2 was used in the following experiment as tumor target 
cells to determine the frequency of splenic macrophages with TNF-secreting 
activity. This experiment was performed exactly as the first experiment was 
except LPS-pretreated macrophages were aliqouted into effector plates at 
concentrations of 200, 400 and 600 splenic macrophages per well. After the 
24 hr incubation period, 50 J.Ll of effector supernatants were added to each well 
of the corresponding 2/F2 target plates. Following incubation of target plates 
and the performance of an MTT assay, absorbance data was recorded and 
analysed by dot plot and limiting dilution analysis. 
Dot plot analysis indicated that maximum killing of sensitive 2/F2 tumor 
targets occurs at the lowest concentration of splenic macrophages (Figure 3.). 
This implies that 2/F2 clones are indeed very sensitive to TNF. At higher 
concentrations of effector cells(~ 200 cells/well) the absorbance values also 
TABLE II 
SUMMARY OF THE EFFECTS OF CRUDE NATURAL 
TNF ON WEHI-164 CLONES 
Mean Absorbance of Mean Absorbance of 
Clone 1Untreated Clones 2Treated Clones a%Killing 
2/F2. 0.0948 0.0073 92.3 
2/G8 0.0585 0.0070 88.0 
2/FS 0.1023 0.0160 84.3 
2/D1 0.0923 0.0147 83.6 
2/D7 0.0575 0.0110 80.9 
2/F3 0.0697 0.0140 79.9 
2/G3 0.0380 0.0117 69.2 
1Untreated: WEHI-164 clones were incubated in cRPMI only. 
2Treated: WEHI-164 clones were incubated with 1:20 crude TNF. 
a%Killing = percent change in absorbance (% Mbs) where; 
% Mbs =Mean Abs [control]- Mean Abs [treated] x 100% 
mean absorbance of contol 
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Figure 3. Dot Plot Analysis of the Effects of Supernatants 
from LPS-Prestimulated Splenic Macrophages on 2/F2 
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indicate total killing. However the absorbance values at these effector cell 
concentrations begin to increase indicating that effector wells may have 
contained contaminating or other interfering cell types. These cell types may 
have enhanced the growth of targets or blocked signal transduction of TNF-
secreting macrophages. Since higher concentrations of macrophage 
suspensions would be expected to contain correspondingly more contamina-
ting cell types it is possible that a lower maximum concentration of effector 
cells should be used in future experiments. 
Limiting dilution analysis (LDA) showed that single-hit kinetics are not 
observed and the frequency of macrophages that secrete TNF cannot be 
determined (Figure 4.). The LDA results also indicated that most of the 
sensitive 2/F2 targets are killed at the lowest concentration of splenic macro-
phages (200 cells/well). At the highest effector concentrations(~ 200 cells 
per well), no additional2/F2 killing occurred. In fact, LDA values actually 
increased slightly. This also indicated that effector cell concentrations may be 
contaminated with cells that enhance the growth or block the killing of 2/F2 
targets in some way. The LDA showed that 2/F2 targets are very sensitive to 
TNF. In fact, the data showed that supernatants, generated at the lowest 
concentration of effector cells, were responsible for the greatest amount of 
killing of 2/F2 targets. Here, the fraction of nonresponding target wells was 
0.033 or about three percent. This suggested that target cells were killed in 
approximately 97% of the target wells. However, because single-hit kinetics 
were not attained, the LDA indicated the need to isolate macrophages in 
higher purity. 
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Response of Sensitive 2/F2 Tumor Targets to Supernatants 
from 1X-11-6 TAM and 1X-11-6 Tumor Cells 
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To determine if the lack of sensitivity encountered in the previous 
experiment was a function of effector cell purity, 1X-11-6 TAM and 1X-11-6 
tumor cells were used as effector cells in the following experiment. The 
results, using 1X-11-6 TAM and tumor effector cells, were also compared with 
the results generated in the previous experiment by normal splenic 
macrophages supernatants. With few exceptions, the 1X-11-6 experiment was 
set up as in the previous experiment. Briefly, TAM were isolated, as outlined 
in Chapter II, Methods and Materials, from tumor cell suspensions by 
rosetting TAM with opsonized SRBC followed by density gradient 
centrifugation over Ficoll-hypaque. The percent of rosetted cells (FeR+ TAM) 
was calculated to be 60%. Since some macrophages may not be capable of 
rosetting opsonized SRBCs, it was not surprising that the percent of TAM, 
determined by microscopic morphological analysis was significantly greater. 
In this case, 75-80% of the isolates were morphologically identical to macro-
phages. These morphological characteristics included a kidney-shaped 
nucleus as well as large amounts of cytoplasm. Following isolation of 1X-11-6 
TAM, tumor cells (non-rosetted cells) were isolated from the same density 
gradient. This was accomplished by removing the non-rosetted cell layer 
with a pipette. 1X-11-6 tumor cells were then washed twice with sterile PBS 
and concentrated by centrifugation at 650 g for 15 minutes. Mter 
centrifugation, the tumor cell pellet was resuspended in 2 ml of cRPMI. 
Following isolation, both cell types were diluted to concentrations of 200, 600 
and 1,000 cells per well in cRPMI, treated with LPS and plated as before. 
When the absorbance of 2/F2 target wells from both parts of the experiment 
had been recorded, the results were again analyzed by dot plot and limiting 
dilution analysis. 
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Dot plot analysis of the effects of 1X-11-6 tumor cell supernatants on 
sensitive targets showed that these supernatants enhance the growth of 2/F2 
targets (Figure 5.). Because the absorbance values indicated that enhance-
ment of target cell growth was occuring, one standard deviation was added to 
the mean absorbance of the 12 control wells to establish the absorbance 
response line (C + S.D.). The results showed that the absorbance values of 
target wells increased as the concentration of effector cells increased. Here, 
absorbance values indicated that tumor cell supernatants had enhanced the 
growth of 2/F2 targets. 
Limiting dilution analysis of the first portion of this experiment showed 
that single-hit kinetics were attained when 1X-11-6 tumor cells were used as 
effector cells (see Figure 6.). Linear regression analysis (LDA) of the line, 
plotted through the LDA data, revealed a coefficient of 0.993. The frequency 
of 1X-11-6 tumor cells that enhanced the growth of TNF-sensitive 2/F2 targets 
was subsequently determined to be approximately 1/825. Since 1X-11-6 
tumors are derived from transformed fibroblasts, enhancement of target cell 
growth seems reasonable. Colony stimulating factors, that are known to be 
potent stimulators of cell proliferation, have been shown to be produced by 
fibro-blasts (25). Of course, it is possible, although not as likely, that 2/F2 
tumor targets might account for some, if not all, of the enhancement of 
growth of target cells. If this is true the growth, in this case, may simply 
reflect the growth pattern of 2/F2 target cells in the presence of addtional 
tumor cell supernatants. 
In the second portion of this experiment, limiting dilution analysis of the 
absorbance data, generated by TAM supernatants, showed that single-hit 
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Tumor Targets. 
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kinetics were not observed and the frequency of TNF-secreting 1X-11-6 TAM 
could not be determined (Figure 7.). The LDA results, generated by these 
supernatants, revealed that no killing could be detected even at the lowest 
concentration of TAM (200 cells/well). The results indicated that the purity of 
the effector cell population was inadequate and the Ficoll Hypaque isolation 
technique did not produce sufficiently pure TAM. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants 
from Untreated MBHR-Isolated 1X-11-6 TAM 
To test the effects of LPS on the TNF secreting activities of tumor associated 
macrophages (TAM) as well as the degree of purity of macrophage isolates, 
TAM were isolated from 1X-11-6 tumor cell suspensions by magnetic bead 
hybrid rosetting (MBHR) and not prestimulated with LPS. The results of the 
previous experiment indicated that isolation of TAM by Ficoll Hypaque 
exclusion resulted in the TAM populations that are somewhat impure (75-
80% at best) and lacked the sensitivity that was necessary to determine the 
frequency of 1NF-secreting TAM. MBHR isolation of 1X-11-6 TAM was 
performed by the method outlined in Chapter II, Methods and Materials. 
Briefly, sheep a-rat-Ig coated magnetic beads (dynabeads) were allowed to bind 
to opsonized SRBCs to produce dynabead rosettes (DBRs). A TAM containing 
1X-ll-6 tumor cell suspension was then mixed, at a ratio of 1: 4, with DBRs to 
produce a MBHR suspension. MBHRs were then immunomagnetically 
isolated from the suspension in an MPC-1 particle concentrator. MBHRs 
were susequently washed with PBS and, following lysis of SRBCs the used 
dynabeads were recovered in the MPC-1. Following the recovery of used 
dynabeads the lX-11-6 TAM were recovered in the lysing effluent and washed 
in sterile PBS. TAM were then resuspended in 5 ml of cRPMI, counted and 
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diluted to concentrations of 200, 400 and 600 cells/well. To determine the 
relative purity of MBHR-isolated TAM, small portions of TAM suspension 
were examined morphologically and rosetted with opsonized SRBCs. 
Morphological analysis revealed that 85-90% of the isolates were TAM. 
However, the percent of rosetted TAM (FeR+) was calculated at 63 percent. 
1X-11-6 TAM were subsequently aliquoted into 96 well microtiter plates and 
incubated for 24 hours. Following incubation, TAM supernatants were added 
to 2/F2 target wells and the MTT assay portion of the experiment completed 
as previously described. 
Limiting dilution analysis of the results showed that the LDA values, 
generated by untreated 1X-11-6 TAM, remained virtually constant. This 
suggested that prestimulation of TAM with LPS was necessary to stimulate 
significant TNF secretion (Figure 8.). However, the results did not indicate 
whether isolation of cells by the MBHR technique provided pure TAM 
populations because single-hit kinetics were not observed and the frequency 
of TNF-secreting 1X-11-6 TAM could not be determined. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants from 
Untreated and LPS-Prestimulated MBHR-Isolated 1X-11-6 TAM 
Since the results of the previous experiment indicated that prestimulation 
of TAM with LPS was necessary to induce TNF secretion, the following 
experiment was performed to confirm this finding and to determine if the 
isolation of TAM by the MBHR technique would actually provide TAM of 
higher purity. This experiment was performed exactly as the previous experi-
ment except that MBHR-isolated 1X-11-6 TAM were either prestimulated 
with LPS (5 JJ.llml) or left untreated prior to use. In addition, TAM were 
aliquoted into effector plates at concentrations of 100, 200 and 400 cells per 
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well to determine the effects of lowering the concentrations of TAM. Also, 
24 control wells were added to untreated effector plates to determine whether 
additional control wells will significantly alter position of the response line. 
Analysis of the purity of the isolates showed that approximately 61% of the 
1X-11-6 TAM rosetted with opsonized SRBCs. However, morphological 
analysis showed that 90% of the isolates were macrophages. 
Dot plot analysis of the absorbance data showed that the absorbance values 
changed in proportion with TAM concentrations (Figure 9.). At the highest 
TAM concentration (400 cells/well) most target cell killing ceased and, in this 
case, the absorbance values increased significantly. 
Limiting dilution analysis of the data indicated that TAM purity was very 
adequate (Figure 10.). In addition, LDA revealed that single-hit kinetics are 
attained at lower TAM concentrations (~ 200 cell/well) (Figure 11.). Here, the 
highest concentration of TAM (400 cells/well) was ignored. Linear regression 
analysis of the results revealed a coefficient of linearity (RA2) of 0.993. If 
MBHR-isolated TAM were pure enough, it seemed clear that, at higher 
concentrations (~ 200 cells/well), the MBHR-isolated TAM populations may 
have contained cells that interfered with the assay. Of course, these 
experimental populations were not 100% pure and, at higher concentrations, 
could have contained interfering cell types. 
Dot plot analysis indicated that untreated (-LPS) 1X-11-6 TAM subpopula-
tions did not secrete significant amounts of TNF (Figure 12.). In fact, 
absorbance values remained virtually constant as the concentration of 
untreated 1X-11-6 TAM increased. The data therefore indicated that no 
significant amount of growth enhancement or killing of 2/F2 target cells 
could be detected. Here, no significant increase in absorbance values could be 
detected, even at the highest concentration of TAM. In fact, there was a 
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somewhat significant decrease in absorbance values at the highest concen-
tration. In addition, the use of 12 additional control wells (24 total) did not 
significantly change the position of the absorbance response line. In this case, 
the absorbance response line for untreated TAM(- LPS) decreased by only 
0.008 and, when compared to the line for prestimulated TAM, indicated that 
12 control wells are sufficient to establish the response line (see Figure 9 and 
Figure 12). 
Limiting dilution analysis of the absorbance data generated by untreated 
1X-11-6 TAM showed that these cells secrete very little, if any, TNF (Figure 
13.). In this case, LDA values remained fairly constant at all concentrations of 
1X-11-6 TAM, single-hit kinetics were not observed and the frequency of TAM 
that secrete TNF constitutively or in response to ubiquitous LPS, could not be 
determined. Comparison, by LDA, of the results generated by prestimulated 
(+ LPS) 1X-11-6 TAM supernatants with those generated by untreated(- LPS) 
1X-11-6 TAM supernatants indicated that LPS is needed to stimulate TNF 
secretion (Figure 13.). The fraction of nonresponding wells for 2/F2 targets 
that were pulsed with untreated TAM supernatants remained consistently 
high at all concentrations. These values ranged from 80-95% (0.80 to 0.95) and 
indicated that, at best, only 20% of the 2/F2 target wells exhibited killing. This 
occurred after corresponding target wells had been pulsed with supernatants 
from untreated TAM that had been aliquoted at 200 TAM per well. In 
contrast, 80% of the target wells exhibited killing at this concentration when 
corresponding target wells were pulsed with LPS-prestimulated TAM 
supernatants. In addition, the results showed that higher concentrations of 
TAM greater(~ 200 cells/well) may contain macrophage subtypes or other 
contaminating cells because target cell killing was almost totally blocked 
beyond this point. Here, 89% (0.89) of the target wells were nonresponding. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants from 
Untreated and LPS Prestimulated MBHR-Isolated MC-4 TAM 
Since the results of the previous experiment indicated that isolation of 
TAM (effector cells) by the MBHR technique provided experimental 
populations of significant purity, the following experiment was performed 
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to determine if this technique would also provide pure experimental 
populations of other TAM. In this case, MC-4 TAM, obtained from a 
methylcholanthrene-induced murine skin tumor were used as effector cells. 
This experiment was performed (using both untreated and LPS-prestimulated 
MC-4 TAM) to compare the results generated by MC-4 TAM, with those 
generated by 1CX-11-6 TAM. Following isolation by the MBHR technique, 
MC-4 TAM were tested for purity. The results showed that 61% rosetted and 
approximately 90% were morphologically identified as macrophages. MC-4 
TAM were subsequently aliquoted into effector plates at concentrations of 200 
and 400 cells/well and incubated. Following the MTT assay, the absorbance 
data was then collected and collated prior to analysis. 
Limiting dilution analysis of the results, generated by prestimulated and 
untreated MC-4 TAM supernatants, also showed that LPS is needed to 
stimulate the secretion of TNF by MC-4 TAM (Figure 14.). The fraction of 
nonresponding target wells, that were pulsed with untreated TAM supernat-
ants, remained consistently high at all concentrations. These values 
remained above 90% (0.90) and indicates that, at best, only 5-7% of the 2/F2 
target wells exhibited killing. In contrast, 65% of the wells contained killed 
clones at this concentration when corresponding target wells were pulsed 
with prestimulated 200 cell/well MC-4 TAM supernatants. These results 
compare very closely with the results generated, in the previous experiment, 
by lX-11-6 TAM. Furthermore, the results showed that higher 
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concentrations of MC-4 TAM(;;:: 200 cells/well), may have contained 
contaminating macrophages or other cell types because target cell killing 
decreased significantly beyond this point. In this case, 68% (0.68) of the target 
wells were nonresponding. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants from 
LP5-Prestimulated Adherence-Isolated 1X-11-6 TAM 
Although the MBHR isolation technique (used in the two previous 
experiments) provided TAM of significant purity, it also proved to be tedious, 
time-consuming and very difficult to perform. The following experiment 
was therefore performed using TAM that were isolated by the adherence 
method outlined in Chapter II, Methods and Materials. The adherence 
method was used in this case to positively select for 1X-11-6 TAM and 
simultaneously exclude (undesirable) tumor cells or non-adherent cells. 
Briefly, heterogeneous 1X-11-6 tumor cell suspensions were aseptically added 
to tissue culture-treated culture dishes at a concentration of 3 x 106 cells/ml in 
cRPMI medium. The cells were then incubated for 30 minutes at 37J C. 
Incubation for 30 minutes allowed enough time for TAM, but not tumor 
cells, to adhere to the bottom of the culture dishes. Non-adherent cells were 
subsequently removed by washing plates with PBS buffer. After washing, 
adherent cell (TAM) layers were recovered with the aid of a cell scraper. 
Adherent cell suspensions were then concentrated by centrifugation, 
resuspended in cRPMI and counted on a hemacytometer. Portions of the 
adherent cells were then tested for purity by rosetting and microscopic 
morphological analysis. The results showed that 71% of the adherence-
isolated TAM rosetted opsonized SRBCs and approximately 95% had 
marophage morphologies. Adherent cells (TAM) were then diluted to 
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appropriate concentrations in cRPMI, prestimulated with LPS and used as 
effector cells. This experiment was performed as before except that TAM were 
used in concentrations of 50, 100, 250 and 400 cells/well. These concentrations 
were used to help determine optimum concentrations, the frequency of TNF-
secreting 1X-11-6 TAM, and to compare the results, at the highest concentra-
tion with the results obtained with MBHR-isolated 1X-11-6 TAM. 
Limiting dilution analysis showed that when corresponding target wells 
were pulsed with prestimulated TAM supernatants, that had been aliquoted 
at 200 cells/well, 80% of the target wells exhibited killing (Figure 15.). Here, 
only 20% (0.20) of the target wells were nonresponding. LDA results also 
showed that higher concentrations of TAM (~ 200 cells/well) may have 
contained macrophage subtypes or other contaminating cells because target 
cell killing decreased significantly beyond this point. The data suggest that 
95% of the target wells were nonresponding when corresponding target wells 
were pulsed with 400 cell/well TAM supernatants. 
Linear regression analysis of the LDA data showed that when the highest 
TAM concentration (400 cells/well) was ignored single-hit kinetics were 
observed (Figure 16.). Since there were two degrees of freedom, the coefficient 
of linearity (R"2) was determined to be 0.981. The frequency of TNF-secreting 
1X-11-6 TAM was then calculated to be approximately 1/170. 
This experiment was subsequently repeated. However, in this case, to 
minimize interference by contaminating cells, adherence-isolated, LPS-
prestimulated 1X-11-6 TAM were aliquoted into effector plates at a maximum 
concentration of 200 cells/well. As in the previous experiment, an MTT 
cytotoxicity assay was performed. The absorbance data were subsequently 
collected and analysed by LDA. 
Linear regression analysis of the LDA results showed that single-hit 
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kinetics were attained and the frequency of TNF-secreting 1X-11-6 TAM was 
estimated to be 1/170 (Figure 17.). In addition, after being pulsed with 200 
cell/well TAM supernatants, 33% (0.33) of the corresponding target wells were 
nonresponding This indicated that 67% of the target wells contained killed 
2/F2 tumor target cells. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants 
from LPS-Prestimulated Adherence-Isolated MC-4 TAM 
In a parallel experiment, performed exactly as the previous experiment, 
LPS-prestimulated MC-4 TAM were used as effector cells. MC-4 TAM were 
also isolated by the adherence method and aliquoted into effector plates at 
concentrations of 75, 125 and 200 cells/well. 
Limiting dilution analysis of data, generated by the MC-4 TAM 
supernatants showed that single-hit kinetics were observed (Figure 18.). 
Linear regression analysis of the LDA results showed that the coefficient of 
linearity (RA2) was 0.986 and the frequency of TNF-secreting MC-4 TAM was 
determined to be 1/200. In addition, 65% of the corresponding 2/F2 target 
wells contained killed cells after being pulsed with 200 cell/well MC-4 TAM 
supernatants. This compares closely with the previous results for 1X-11-6 
TAM supernatants where 67% of the 2/F2 target wells exhibited killing. 
Response of Sensitive 2/F2 Tumor Targets to Supernatants 
from LPS-Prestimulated Adherence-Isolated C3H/HeN 
Murine Splenic Macrophages 
As a comparsion, a similar, parallel experiment was performed exactly as 
the previous experiment except that LPS-prestimulated splenic macrophages 
were used as effector cells. This experiment was used to determine 
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what functional similarities, if any, exist between normal splenic macrophage 
and tumor associated macrophage (TAM) populations. 
Limiting dilution analysis of the data, generated by the splenic macrophage 
supernatants showed that single-hit kinetics were observed (Figure 19.). 
Linear regression analysis of the LOA results (also see Figure 19.) showed 
that the coefficient of linearity (RA2) was calculated to be 0.980 and the 
frequency of TNF-secreting splenic macrophages was estimated to be 1/150. 
In addition, 77% of the corresponding target wells contained killed 2/F2 target 
cells after being pulsed with 200 cell/well macrophage supernatants. 
Comparison of the data, generated by adherence-isolated TAM and normal 
spenic macrophage supernatants, suggests that they have nearly equivalent 
TNF-secreting activities. The frequencies of macrophages that secrete TNF 
ranged from 1/200 (0.5%) for MC-4 TAM to 1/150 (0.7%) for normal murine 
splenic macrophages. The results from the three previous experiments also 
showed that the adherence method of isolating macrophages from solid 
tissues proved to be the most practical method in terms of speed, 
convenience, costs and accuracy of results. The adherence technique was used 
as a method of choice to isolate TAM in the remainder of this study. 
Response of anti-TNF-a-pretreated 2/F2 Tumor Targets 
to Supernatants from MC-4 and lX-11-6 TAM 
The results, generated in the preceding three experiments, suggested that 
rare subsets of prestimulated TAM were capable of killing 2/F2 tumor target 
cells. However, the results of these experiments did not indicate how much, 
if any, of the observed target cell killing was actually due to secretion of TNF 
by TAM. The following assay was designed to address this question. Briefly, 
MC-4 and 1X-11-6 TAM were isolated by the adherence technique. TAM were 
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then prestimulated with LPS (5 JJ.g/ml) and aliquoted into effector plates. At 
the same time, 2/F2 tumor target cells were aliquoted, at 1.25 x 104 cells/ml, 
into 60 wells of each corresponding target plate. As in previous experiments, 
controls were added to target plates to establish baseline absorbances and an 
absorbance response line. Effector and target plates were then incubated at 37> 
C. After 22 hours of incubation, target wells were either left untreated, treated 
with whole rabbit anti-1NF-a. serum (anti-1NF-a., 2000 neutralizing 
units/ml) to block 1NF activity or treated with whole rabbit anti-bovine 
serum (Ra.-BS). R-a.-BS antisera was used to test whether normal 
components in the cRPMI medium are capable of blocking 1NF activity. 
Following the addition of antisera to corresponding wells, target plates were 
reincubated for 2 hours to allow time for antibody binding. Following 
reincubation, target wells were pulsed with corresponding TAM supernatants 
and reincubated for an additional 6 hours. After this final incubation period, 
an MTT assay was performed and the absorbance data collected and analysed 
by dot plot and comparative analysis. 
The results of the experiment, summarized in Table III, showed that anti-
1NF-a. antisera blocks all of the killing of 2/F2 tumor targets by TAM super-
natants (Table III.). In this case, none (0%) of the antibody-treated targets were 
killed by 1X-11-6 TAM supernatants. In contrast, 65% of the corresponding 
untreated target cell cultures exhibited killing. These targets were pulsed with 
prestimulated 1X-11-6 TAM supernatants but had not been pretreated with 
anti-1NF-a. antisera. Similar results were obtained with MC-4 TAM 
supernatants. Here, only 2% of antibody treated target wells contained killed 
targets. In contrast, 68% of the untreated target wells exhibited killing. The 
fact that an insignificant amount (2%) of the antibody treated target wells 
showed killing probably reflects normal cell death or loss of viability. 
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TABLE III 
SUMMARY OF THE EFFECTS OF WHOLE ANTI-TNF-a ANTISERA 
ON THE TNF ACTIVITY OF MC-4 AND 1X-11-6 TAM 
=== = 
TAM 
= -- - a Treatment 
= = 
-
==== 
========================== =======~======w=== =====maw 
MC-4 
MC-4 
MC-4 
1X-11-6 
1X-11-6 
-- -
anti-TNF-a 
Ra-BP 
Control 
anti-TNF-a 
Control 
-- ==== - --- - = = - - -
= 
2 
83 
68 
0 
65 
- ----
aTargets were: 1.) incubated with LPS-prestimulated TAM supernatants only 
(control). or 2.) pretreated with 10 ~ of 10-1 dilute whole Rabbit anti-Bovine 
Serum [to test whether cRPMI medium components such as fetal calf 
serum will block killing] then subsequently incubated with LPS prestimul-
lated TAM supernatants (Ra-Bs). or 3.) pretreated with anti-TNF-a antisera 
(2000 neutralizing units/ml) [to show that TNF was secreted by TAM and to 
determine if TNF was solely responsible for MC-4 and 1x-11-6 TAM 
tumoricidal activity] then subsequently incubated with LP5-prestimulated 
TAM supernatants 
b% Killing= Fraction of responding wells x 100 % = 1-F0 x 100 %; where Fo is 
the fraction of nonresponding wells. 
65 
However, it is more likely that the antibody failed to bind to some of the 
targets. The results gave direct evidence that killing of targets by TAM 
supernatants was due solely to the secretion of TNF by prestimulated TAM. 
These results also correlate favorably with results of prior experiments in 
which 65-67% of the target wells responded after treatment with LP5-
prestimulated TAM supernatants. Also, the results suggested that 83% of the 
target wells, that were pretreated with Ra-BS antisera then pulsed with MC-4 
TAM supernatants, exhibited killing. This comparison suggested that an 
additional 15% of the R-a-BS pretreated target wells (83%-68%) showed 
killing. Since Ra-BS could have bound to components of fetal calf serum 
(FCS) in the cRPMI medium and, since FCS components should account for 
at least some of the the growth enhancement activity of the medium, it is 
possible that Ra-BS may have blocked some of this growth enhancement 
activity. Ra-BS antisera may have therefore acted to synergistically enhance 
the effects of TNF. 
Response of 2/F2 Tumor Targets to Supernatants from lX-11-6 TAM 
that had been Prestimulated with Various Doses of IFN-r 
The second major goal of this study was to estimate the cytotoxic activity of 
tumor associated macrophages in response to LPS, macrophage-colony 
stimulating factor (M-CSF) and interferon-gamma (IFN-y). Optimal concen-
trations of LPS and M-CSF that were required to activate TAM had been 
previously established (14, 20). However, the required optimal dose of IFN-r 
needed to be established. This was accomplished by utilizing an MTT 
cytotoxicity assay. Briefly, lX-11-6 TAM were arbitrarily chosen and used as 
effector cells. These were isolated by the adherence technique and prestim-
ulated with either LPS (5 f..Lg/ml) or concentrations of IFN-ywhich ranged 
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from 20 to 20,000 units/mi. Prestimulated TAM were then aliquoted, at 200 
cells/well, into effector plates. In addition, a duplicate effector plate was used 
to eliminate the possibility that product (IFN-y) carryover would kill 2/F2 
tumor targets. The duplicate plate contained TAM that had been prestimula-
ted with 200 units/ml of IFN-y. However, the wells of this duplicate plate 
were thoroughly washed after 5 hours of incubation with sterile PBS to 
remove IFN-y. At the same time, 2/F2 tumor target cells were aliquoted, at 
1.25 x 104 cells/ml, into corresponding target plates. As in previous 
experiments, additional wells of the target plates were aliquoted with target 
cells or cRPMI medium and used as controls to establish a mean absorbance 
response line and absorbance baselines. Effector and target plates were then 
incubated at 37> C. After 24 hours of incubation, target wells were pulsed with 
supernatants from corresponding effector plates. Also, an additional target 
plate was pulsed with supernatants from the washed effector plate. Target 
plates were then incubated for 48 hours, an MTT assay was performed and the 
absorbance data collected. 
Dose response analysis of the absorbance data showed that the mean 
absorbance of target wells decreased significantly when they were treated with 
supernatants from TAM that were prestimulated with increasingly higher 
doses (200-20,000 units/ml) of IFN-y (Figure 20.). Comparison of the results 
showed that supernatants, produced by TAM that had been prestimulated 
with a low dose (20 units/ml) of IFN-y, had little or no effect on 2/F2 targets. 
In fact, this observation compares closely with the results for the baseline 
controls. The mean absorbance of these control wells, was 0.587. However, at 
higher doses(~ 200 units/ml), mean absorbance of target wells decreased 
dramatically as the concentration of IFN-y increased. Also, IFN-y itself does 
not kill tumor target cells because the mean absorbance of target wells, that 
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had been pulsed with supernatants from the washed effector plate (200*), was 
lower than the mean absorbance of target wells that were pulsed with 
supernatants from the corresponding unwashed effector plate. Here, a 
comparison of the results indicated that supernatants from the washed plate 
are more efficient at killing target cells. However, it is more likely that 
membrane-associated TNF was not removed when the IFN--y was washed 
from the wells of the duplicate effector plate. In this case, the additional TNF, 
that could have accumulated during the extended incubation period (5 
hours), may account for the observed additional decrease in target well mean 
absorbance. The optimum concentration of IFN-y was determined to be 2,000 
units/mi. At this concentration, mean absorbance was reduced by almost 40% 
(0.587- 0.358/0.587 X 100%). At the highest concentration of IFN-y (20,000 
units/ml), there was only a slight reduction in target well mean absorbance. 
In this case, mean absorbance only decreased an additional 3.5%. However, 
this slight decrease required a 10-fold increase in the concentration of IFN--y 
and did not merit using the highest concentration as an optimal dose. 
Response of 2/F2 Tumor Targets to Supernatants from 
LPS, M-CSF and IFN-y-prestimulated lX-11-6 TAM 
The final experiment in this study was designed to estimate the cytotoxic 
activity of prestimulated TAM. Again, 1X-11-6 TAM were arbitrarily chosen 
and used as effector cells. To determine their cytotoxic activity, lX-11-6 TAM 
were prestimulated with LPS, M-CSF and IFN-y. These were used, alone or in 
specific combinations, to stimulate the secretion of TNF. This experiment 
was performed in much the same manner as the previous experiment. 
However, a washed duplicate efffector plate, to test for product carryover, 
was not needed and, was not used. TAM were prestimulated with single or 
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combination doses of M-CSF (10,000 Units/ml), IFN-r (2,000 Units/ml) and 
LPS (5 J.Lg/ml) prior to incubation. Prestimulated TAM were then aliquoted 
into effector plates and incubated for 24 hours. Wells of target plates, 
containing 1.25 x 104 2/F2 cells/ml, were then pulsed with corresponding 
effector (TAM) supernatants, incubated 48 hours, pulsed with MTT and, 
following a 6 hour reincubation period, solubilized with isopropanol-HCL. 
Target well absorbance data were subsequently read and analysed. 
The results of this experiment, summarized in Table IV, showed that 
prestimulation of lX-11-6 TAM with LPS, M-CSF and IFN-r induces the 
production of supernatants with the greatest cytotoxic activity (see Table IV). 
The cytotoxic activity of prestimulated TAM was estimated by calculating the 
percent change (decrease) in mean absorbance. Comparative analysis of the 
cytotoxic activities of TAM supernatants indicated that prestimulation of lX-
11-6 TAM with LPS, M-CSF and IFN-r produces a 35% increase in cytotoxic 
activity. In contrast, cytotoxic activity increased by only 3.3% when TAM were 
prestimulated with LPS alone. M-CSF alone was only slightly more effective 
than LPS in increasing cytotoxic activity of TAM. Here, M-CSF only increased 
the cytotoxic activity of TAM by 4%. This slight increase seems reasonable 
since M-CSF may stimulate the proliferation of TAM as well as TNF-secreting 
subsets of TAM. In fact, M-CSF, alone or combined with other factors, seemed 
to have only a slight additive effect on the increase in the cytotoxic activity of 
TAM supernatants. In comparison, when lX-11-6 TAM were prestimulated 
with IFN-r there was a corresponding 27% increase in cytotoxic activity. 
Comparison of the results, generated by IFN-y-prestimulated TAM with those 
generated by LP5-prestimulated TAM, indicated that IFN-r was 8 times more 
efficient at increasing the cytotoxic activtiy of lX-11-6 TAM. It seemed clear 
that IFN-r was a powerful stimulant of the cytotoxic activity of TAM. 
TABLE IV 
SUMMARY OF THE EFFECTS OF LPS, M-CSF AND IFN-yON THE 
CYTOTOXIC ACTIVITY OF 1X-11-6 TAM SUPERNATANTS 
Treatmenta Mean Absorbanceb Cytotoxic Activityc 
(% .1 Mean Absorbance) 
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----- r -----
-----------------
----
----------control 
Untreated2 
LPS 
M-CSF 
LPS +M-CSF 
M -CSF + IFN -y 
IFN-y 
IFN-y +LPS 
LPS+ M -CSF + IFN -y 
.296 
.277 
.268 
.266 
.249 
.208 
.202 
.186 
.180 
0.0 
0.0 
3.3 
4.0 
10.1 
25.0 
27.1 
33.0 
35.0 
=-================-==================-=-=======-==mama 
a Targets were: 1.) Incubated with cRPMI or 2.) Pulsed with non-
prestimulated 1X-11-6 TAM supernatants or 3.) Pulsed with prestimulated 
1X-11-6 TAM supernatants. 
b Mean Absorbance = total absorbance/ 60 
cCytotoxic activity(% .1 Mean Absorbance) was estimated by calculating 
the percent change (decrease) in mean absorbance 
where; Cytotoxic activity=% .1 Mean Absorbance 
% .1 Mean Absorbance= Untreated Mean Abs -Treated Mean Abs x 100% 
Untreated Mean Abs 
1control: targets were incubated with cRPMI medium only. 
2untreated: targets were pulsed with non-prestimulated 1X-11-6 TAM 
supernatants. 
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However, it is not clear whether IFN-y simply stimulated an increase in TNF 
secretion by existing TNF-secreting TAM subsets or stimulated additional 1X-
11-6 TAM to secrete TNF or both. It is also possible that IFN-y induced TAM 
to produce other, unreported, factors that may have rendered 2/F2 targets 
more susceptible to the normal cytotoxic activity of TAM. 
Summary of Results 
The results of this study show that, in the absence of cell to cell contact, 
both splenic and tumor associated macrophages must be prestimulated to 
exhibit significant cytotoxic activity. The results also indicate that rare subsets 
of 1X-11-6 tumor cells enhance the growth of TNF-sensitive 2/F2 tumor target 
cells (Figure 6.). This evidence suggests that tumor cells may have the 
capacity to enhance the proliferation of other cell types, including TAM, in 
vivo. Also, the results show that rare subsets of splenic macrophages and 
TAM are capable of TNF secretion after prestimulation with LPS. The 
frequencies of both normal and tumor associated types of TNF-secreting 
macrophages are strikingly similar. This similarity suggests that TAM are 
probably not derivatives of elicited macrophage populations. Furthermore, 
the complete blocking of TNF activity with anti-TNF-a antibody provides 
direct evidence that TNF is secreted by prestimulated MC-4 and lX-11-6 TAM 
and is solely responsible for their cytotoxic activity. In addition, the 
prestimulation of TAM with single and combination doses of LPS and M-CSF 
slightly enhances the cytotoxic activity of TAM. Prestimulation of TAM with 
IFN-y, alone or in combination with LPS and M-CSF can greatly enhance the 
secretion of TNF and, therefore, the cytotoxic activity of TAM. 
CHAPTER IV 
DISCUSSION 
The results of this study show that an average of approximately 1/180 
1X-11-6 TAM, MC-4 TAM and murine splenic macrophages secrete tumor 
necrosis factor and are threrefore cytotoxic for tumor target cells. These 
results provide the first reported estimates of the frequency of TAM that 
secrete TNF. The determination of these frequencies is important because the 
existence of low frequencies of cytotoxic TAM suggests the existence of low 
effector to target ratios in vivo. It is therefore reasonable to conclude that, in 
the presence of functionally diverse cell populations within rapidly growing 
tumors and, in the absence of stimulation, the frequency of cytotoxic TAM 
would be too low to facilitate tumor rejection in vivo. 
In other respects, the results of this study are consistent with previous 
observations and show that, in the absence of cell to cell contact, both murine 
splenic macrophages and tumor associated macrophages must be induced to 
secrete TNF (2, 27, 28). Bacterial LPS has been previously shown to stimulate 
the tumoricidal or cytotoxic activity of normal and tumor associated macro-
phages (27). Also, Mcintosh et al have shown that stimulation of macrophage 
cytotoxic activity is a multistage process in vivo (21). Macrophages exhibit 
little or no cytotoxic activity in the absence of stepwise exposure of 
macrophages to activating factors, such as IFN-y and LPS (21). In this study, 
the cytotoxic activity of experimental macrophages was enhanced 
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significantly in the presence of these factors and adds supporting evidence to 
Mcintosh's data. 
Our results also show that rare subsets of lX-11-6 tumor cells enhance the 
growth of TNF-sensitive 2/F2 tumor target cells (Figure 6.). Approximately 
1/825 of these tumor cells were capable of enhancing the growth of targets. 
This evidence suggests that tumor cells have the capacity to enhance the 
proliferation of other cell types, including TAM. It is possible that the 
observed enhancement of 2/F2 target cell growth could have been produced 
by contaminating cell types. However, since the purity of the lX-11-6 tumor 
cells was not determined, the results of this experiment are reasonable 
because single-hit kinetics were observed. Also, since the lX-11-6 tumor is a 
fibrosarcoma, the results presented here may further support a previous 
report which suggests that fibroblasts produce potent colony stimulating 
factors (25). In fact, a more recent report shows that M-CSF activity was 
detected in lX-11-6 and MC-4 tumor cell supernatants and, in addition, these 
supernatants dramatically enhanced the proliferative response of lX-11-6 and 
MC-4 TAM targets (20). 
In order to determine the frequency of cytotoxic macrophage subsets within 
experimental populations, it is evident, from the results generated in this 
study, that macrophages must be isolated in high purity. In this regard, the 
method of isolation seems to be the most critical parameter. Isolation of 
TAM by density gradient centrifugation over ficoll-hypaque produced 
experimental TAM populations that were, approximately 80% pure. In this 
case, single-hit kinetics were not observed and the frequency of cytotoxic TAM 
could not be determined. In contrast, TAM that were isolated by MBHR and 
adherence methods were at least 90% pure. Here, isolates were pure enough 
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to allow for the determination of the frequency of TNF-secreting macrophage 
subsets by limiting dilution analysis. 
Two noteworthy observations were encountered in this study. First, as 
previously mentioned, the percent purity of macrophage isolates depended 
on the method of isolation and was determined (in part) by SRBC rosetting. 
The percent of macrophages which rosetted opsonized SRBCs was, on 
average, approximately 60-65%. In sharp contrast, the percent of these cells, 
that were morphologically identified as macrophages, varied considerably. In 
this case, the purity ranged from 75-80% for density gradient isolates to 
approximately 95% for the adherence isolates. This observation suggests that, 
although as many as 95% of the isolates were morphologically identified as 
macrophages, approximately 40% of the isolates were incapable of rosetting 
SRBCs. This indicates that SRBC rosetting is not a good method of 
determining the percent purity of experimental macrophage populations. 
Since macrophages are known to fuse with other macrophages and form 
multinucleated cells it is possible that TAM, which do not express Fe receptors 
(FeR-), are actually the fusion products of TAM and transformed cells. Also, 
since TAM reside in an abnormal environment, it may be possible that FeR-
TAM are transformed macrophages. Of course, it is more likely that FeR-
TAM actually represent TAM with reduced FeR avidity. In fact, evidence 
reported by Moore and McBride suggests that less mature TAM exhibit lower 
FeR avidity and this avidity varies from tumor to tumor (15, 16). It is 
reasonable to speculate that the frequency of TAM with low FeR avidity will 
therefore dictate the percent of TAM that can be identified by the SRBC 
rosetting technique. TAM might be isolated in higher purity by binding 
antibody to a cell surface marker (i.e. F4/80 or MAC-1) that is common to all 
macrophages and using fluorescence activated cell sorting techniques (FACS). 
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Once pure(~ 99%) macrophage populations are isolated, they could be tested 
for purity by the SRBC rosetting technique. If an average of 40% of these 
FACS isolates do not rosette opsonized SRBCs, the results would suggest that 
a significant proportion do not possess Fe receptors or, at least, have low FeR 
avidity. This might also suggest that the TAM populations used in this study 
would be expected to contain FeR-, FeR+ and low avidity FeR+ TAM subsets. 
Of course these may or may not have affected the results of this study. 
The second noteworthy observation here was that, even though 1X-11-6 
and MC-4 TAM are diverse in etiology, both had virtually the same capacity 
to secrete TNF. This observation suggests that the results of this study may 
apply to a wide range of tumors. Also, less than 1% of experimental MC-4 
and 1X-11-6 TAM populations secreted TNF and, in addition, significant 
quantities of TNF were only secreted after TAM had been prestimulated with 
LPS or other factors. This observation implies an absence of recognition of 
the tumor by the host immune system. However, it should be noted that the 
TAM used in this study were from rapidly growing (progressive) tumors. 
Therefore, the evidence presented here may not apply to tumors in early 
stages of development. In fact, Burnham has shown that in vivo tumor 
establishment is antagonized by the presence of macrophages and, in contrast, 
macrophages augmented the growth of tumors at later stages of progression 
(Dr. Kim Burnham, unpublished results). Additional reports show that TAM 
secrete growth factors (7, 15), and, enhance the growth of some established 
tumors in vivo (15). Burnham and Reed have shown that super-natants 
from MC-4 and 1X-11-6 tumors stimulate the in vitro proliferation of their 
respective TAM (20). Since the results of our study suggest that the 
frequencies of TNF-secreting MC-4 and 1X-11-6 TAM are too low to inhibit 
tumor growth, it seems reasonable to conclude that, during progression, TAM 
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and their tumor hosts may achieve a stable yet complex functional relation-
ship that is mutually beneficial. 
The results of this study also shows a striking similarity in the frequencies 
of 1X-11-6 and MC-4 TAM as well as normal splenic macrophage subsets 
which secrete TNF. This similarity suggests that an ontogenic relationship 
may exist between these etiologically distinct macrophages. These 
experimental macrophage subsets may therefore have arisen from the same 
circulating monocyte pool. Also, in contrast to inflammatory macrophages, 
which are elicited during an immune response and fully activated for 
cytotoxic activity, the macrophages used in this study secrete significant 
quantities of TNF only after prestimulation. This evidence suggests that 
1X-11-6 and MC-4 TAM are not derivatives of elicited macrophage popula-
tions. In fact, Burnham and Reed have shown that MC-4 and 1X-11-6 TAM 
exhibited the proliferative characteristics of resident macrophages and, 
therefore, do not behave like elicited macrophages (20). 
It is clear that higher concentrations (~ 200 cells/well) of macrophage 
isolates may contain cells that produce factors which block or override the 
cytotoxic activity of macrophages. In most cases, where the frequency of TNF-
secreting TAM was determined, the LDA results of this study showed that 
nearly all cytotoxic activity was lost at the highest concentrations of 
macrophages. Contaminating cells may be macrophage subsets which 
produce factors that enhance the growth of 2/F2 targets or block the effects or 
production of TNF by prestimulated macrophage subsets. This seems 
reasonable since Moore and McBride have shown that TAM exhibit 
functional heterogeneity (16). This heterogeneity may help account for the 
loss in cytotoxic activity because TAM are known to produce a variety of 
growth enhancing factors (7, 14). In contrast, macrophages are also capable of 
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producing prostaglandin E2 (PGE2) which is suspected of playing a role in 
down-regulating 1NF production (11). Indeed, it is possible to test for the 
involvement of PGE2 by adding indomethacin to TAM cultures to inhibit 
PGE2 production. The restoration of cytotoxic activity in such a way would 
suggest that PGE2, produced by TAM subsets, is capable of regulating 1NF 
production. Inhibition of 1NF production by contaminating tumor cells 
could also explain the observed loss of TAM cytotoxic activity. In fact, Rybski 
and Scuderi et al have shown that that tumor supernatants do inhibit TNF 
production (23). However, the results presented in this study show that a 
frequency of approximately 1/825 lX-11-6 tumor cells can enhance the growth 
of sensitive 2/F2 tumor targets. Assuming that the loss of cytotoxic activity 
was due to enhancement of target cell growth and, since macrophage 
cytotoxic activity was almost totally lost at concentrations of 400 cells per well, 
it seems that this concentration would not contain enough contaminating 
tumor cells to cause the the observed loss in cytotoxic activity. One way to 
determine what cell types are causing this loss would be to use 100% pure 
experimental macrophage populations in future studies. As discussed earlier, 
this would probably require the investigator to use a cell surface marker that 
is common to all macrophages. If the cytotoxic activity of supernatants, 
produced by pure macrophage populations, is still lost at high cell 
concentrations (::?: 200 cells/well), the results would indicate that diverse 
macrophage subsets are responsible for the loss in cytotoxic activity. Of 
course, if cytotoxic activity is restored, the results would indicate that 
sufficient numbers of other contaminating cells are present. 
This study also showed that the cytotoxic effects of TAM supernatants 
were completely blocked when 2/F2 tumor targets were initially pretreated 
with anti-1NF-a antisera. This provided direct evidence that 1NF is secreted 
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by prestimulated MC-4 and 1X-11-6 TAM and is solely responsible for their 
observed cytotoxic activity. It also lends support to evidence presented in a 
separate study by Lord and Wilson et al. They howed that the cytotoxic 
activity of EMT6 TAM supernatants was also blocked by anti-TNF antibody 
(33). In our study visual observations showed that many of the target wells, 
that had been pulsed with 200 cell/well TAM supernatants, exhibited marked 
decreases in cell density. Since TNF has been shown to alter target cell 
metabolism by suppressing lipoprotein lipase activity, and since the enzymes 
associated with energy metabolism (i.e. NADH) are known to convert MTT 
(used in our assays) to formazan product, these observations indicate that 
target cells are killed by lNF and not simply metabolically suppressed. It is 
interesting to note that whole rabbit anti-bovine serum (Ra-BS) was used in 
this portion of our study to test whether components of the cRPMI medium 
are capable of blocking TNF activity. The results showed that 83% of the 
target wells, that were pretreated with anti-bovine serum, exhibited killing. 
In contrast, only 68% of the those target wells, that were not pretreated with 
R-a-BS antisera prior to the addition of TAM supernatants, exhibited killing. 
This comparison suggests that an additional 15% of the R-a-BS pretreated 
target wells showed killing. It is possible that targets were simply more 
sensitive to the effects of TNF in the presence of R-a-BS. However, since 
Ra-BS may have bound to specific fetal calf serum (FCS) components in the 
cRPMI medium, it is more likely that Ra-BS may have blocked the growth 
enhancement or anti-TNF activity of these components. The results 
therefore support the finding that human serum, in the presence of super-
natants from fibroblast and tumor cell cultures, suppresses the secretion of 
TNF by blood mononuclear cells (23). R-a-BS may therefore have acted to 
seemingly enhance or intensify the secretion of TNF. In this regard, it is 
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possible to test whether R-cx-BS antiserum can bind to FCS components and 
block their growth enhancement properties. This can be resolved by 
performing an experiment in which 2/F2 target plates are incubated in the 
presence of Fcs+ and FCS free medium. In this case, half of the target plates 
would be treated with R-cx-BS antiserum. MTI assays could then be 
performed on the target plates. If analysis of the data shows that growth 
enhancement of target cells does occur but is substantially reduced in the 
presence of R-cx-BS antiserum the results would show that the antiserum 
does block the activity of FCS components and may account for the 15% 
increase the target cell killing generated by TAM supernatants. 
Additional data generated in this study, show that the cytotoxic activity of 
TAM was substantially increased in the presence of recombinant forms of 
IFN-y and M-CSF. IFN-y and M-CSF are known to stimulate TNF secretion 
by macrophages, (21, 22). However, in our study M-CSF was only slightly 
more effective than LPS at enhancing the cytotoxic activity of TAM. In sharp 
contrast, recombinant IFN-y, alone or in combination with LPS and M-CSF, 
stimulates a significant increase in TAM cytotoxic activity. Although TAM 
have recently been shown to express M-CSF receptors on their surface (22), 
the results of this study represent the first comprehensive report of the 
enhancement of TAM cytotoxic activity in the presence of M-CSF and IFN-y. 
Since both prestimulated normal and tumor associated macrophages have 
been shown to secrete TNF (14, 33) and, since the results presented in this 
study provided direct evidence that TAM can be induced to secrete TNF, it is 
reasonable that the cytotoxic activity of TAM, as described above, is accurate. 
The mean absorbance values, generated in the MTI assay, are proportional to 
target cell viability. Cytotoxic activity was measured, in this case, by 
calculating the percent change in the mean absorbances of untreated versus 
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treated target wells. It is interesting to note that only an additional 8% 
increase in the cytotoxic activity of lX-11-6 TAM was observed when TAM 
were prestimulated with LPS, M-CSF and IFN-y. This 8% increase in cytotoxic 
activity represents a rather small increase over the cytotoxic activity observed 
for IFN-y alone. This leveling off suggests that TAM may reach a cytotoxicity 
threshold. Above this threshold, it is possible that no additional TAM can be 
induced to secrete TNF. Of course, it is also possible that no additional TNF 
can be secreted by existing TAM. Additional assays may be used in future 
correlative studies to test whether IFN-y, M-CSF or other factors induce 
increases in the frequency of TNF-secreting TAM subspecies or simply induce 
existing subsets to increase their secretion of TNF. In fact, to determine the 
cytotoxic activity of TAM, a cytokine specific immunospot (ELISPOT) assay 
(24, 28) may offer a practical alternative to the LDA and MTT assays that were 
used in this study. The ELISPOT assay is derived from the enzyme-linked 
immunosorbant assay or ELISA. However, unlike the ELISA, the ELISPOT 
assay is run in the solid phase. Briefly, macrophages can be allowed to adhere 
to the bottom of tissue culture-treated plastic dishes. Contaminating (tumor) 
cells would then washed from the dishes. After washing, TAM can be 
harvested, washed, resuspended in medium and counted using a hemacyto-
meter. Macrophages can then be allowed to adhere to the bottom of culture 
dishes or the wells of 96 well microtiter plates, incubated in the presence of 
prestimulating factors (i.e. LPS and IFN-y) and allowed time to produce TNF. 
An appropriate anti-TNF-a antibody could then be added to the culture dishes 
or plate wells and allowed to bind to secreted TNF. This antibody would 
serve as the primary (1°) antibody. After completion of the initial stages of 
the assay using ELISA techniques, soluble substrate can then be suspended in 
molten but cooled (3i> C) agarose gel and added to the plate. Sufficient time 
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would then be allowed for the gel to harden and for the enzyme-substrate 
reaction to occur. The enzyme-substrate reaction results in the production of 
a visible colored product wherever macrophages have produced TNF. Since 
the total number of adherent macrophages would have been previously 
determined, the frequency of TNF-secreting TAM could then be calculated by 
determining the number of colored spots. In addition, the change in both the 
frequency of TNF-secreting TAM as well as changes in the cytotoxic activity of 
TAM, in response to LPS, IFN-y and other factors, could be determined. Here, 
changes in frequencies can be determined by visual inspection. Also, since 
the diameter of the colored spots is proportional to the amount of TNF 
secreted, changes in cytotoxic activity could be determined by calculating the 
area of each spot. Changes in the amount of TNF produced or the number of 
TAM that secrete TNF would naturally be expected to be a function of the type 
of factors used to prestimulate macrophages. In future studies, it may also be 
possible to use the ELISPOT to test the accuracy of the data generated in this 
study and, at the same time, to determine whether their are any inherent, yet 
unidentified, problems with this study. 
There were several potential problems of importance encountered in this 
study. The first potential problem is the possibility that removal of adherent 
macrophages from culture dishes may have somehow affected the overall 
functional performance of these effector cells. Macrophages may have been 
affected in such a way that an accurate assessment of the frequency of TNF-
secreting macrophages and their cytotoxic capabilities, in vivo, may not be 
precisely portrayed. However, the results, generated with both adherence and 
MBHR-isolated TAM, proved to be virtually indistinguishable. This seems to 
indicate that neither macrophage isolation technique has any great effect on 
macrophage functions. In fact, it wasn't until macrophages were isolated in 
relatively pure form, using these techniques, that it became possible to 
determine the frequencies of 1NF-secreting macrophage subsets. 
82 
Since bacterial LPS stimulates the production of 1NF by macrophages and, 
since it is ubiquitous in nature, the second potential problem with this study 
is the possibility that the cRPMI medium may have inherently contained 
small amounts of LPS. Contamination of the media with LPS could induce 
macrophages to secrete additional1NF. This may result in an increase in 
cytotoxic activity and may not accurately represent the true cytotoxic capability 
of TAM. It is possible to use an ELISPOT or MTT assay to test for the presence 
of ubiquitous 1NF in the growth medium. The growth medium, used to 
culture IFN-y-prestimulated macrophages, could be pretreated with anti-LPS 
antiserum. In this case, a decrease in cytotoxic activity would indicate the 
presence of LPS in the medium. Steps could then be taken to help insure the 
exclusion of ubiquitous LPS from the media. This might best be 
accomplished by taking extra precautions in the preparation of growth 
medium prior to use. Of course, it might be possible to use these techniques 
in conjunction with anti-LPS antiserum to establish the amount of additional 
cytotoxic activity that is attributed to ubiquitous LPS. This additional activity 
(if any) could then be accounted for when the cytotoxic activity of 
macrophages is calculated. 
The Mean absorbance values of controls varied from experiment to 
experiment and may be an additional source of error in this study. Variations 
in mean absorbance values may be due to the fact that outer wells tended to 
dry out during incubation. These wells generally tended to have slightly 
higher absorbance values than wells near the center of the target plates. 
However, since it was not always possible to use fresh medium and since 
medium components have a finite half-life and lose activity over time it is 
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conceivable that, the variations in mean absorbance of controls may be the 
indirect result of the loss of growth enhancement activity of stored medium. 
To summarize, this study represents the first reported evidence in which 
the frequency of 1NF-secreting TAM subpopulations has been established. 
The determination of these frequencies shows that only rare subsets of both 
TAM and splenic macrophages are capable of secreting 1NF. Direct evidence 
has also been presented which shows that prestimulated TAM do indeed 
secrete 1NF and this secreted 1NF is solely responsible for the killing of 
sensitive 2/F2 tumor targets. Also, the data suggest that the cytotoxic activity 
of TAM, in response to LPS, M-CSF and IFN-y, can be greatly enhanced. 
Since IFN-y and M-CSF are naturally occurring cytokines, the increased 
enhancement of the cytotoxic activity of TAM in response to individual or 
combined doses of these cytokines may prove to be an effective approach to 
cancer immunotherapy in vivo. 
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